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ABSTRACT
Proteomic Analysis of Mammary Epithelial Cell Development
Alyssa Kay Conly
In this set of studies, a proteomic approach was used to investigate the protein profile of
the mammary epithelial cell (MEC) through different stages of mammary development.
The HC11 cell line was used to investigate protein changes between undifferentiated and
differentiated MEC, which represent the pregnant and lactating states of the cells. This
comparison revealed an interesting differential expression profile underscoring many
recognized processes that occur in differentiated MECs, while others unveiled differences
between MEC differentiation in vitro and in vivo. Primary MEC were also isolated from
virgin, pregnant, and primiparous quiescent mice to compare the virgin state of the cell to
the other two stages of development. These comparisons added to a previous dataset of
primary isolated MEC and generated data that implied a surprising level of activity in
virgin MEC relative to the other stages of development investigated. Differentially
expressed proteins in the virgin and primiparous quiescent comparison also added to
evidence of persisting changes occurring in the gland after a full term pregnancy that are
implicated in the risk for breast cancer development. Data sets generated in the same
manner from differentiating MEC were used in the development of a database to help
manage the growing list of differentially expressed proteins and aid in the identification
of potential interesting patterns of regulation during mammary development and
differentiation.
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CHAPTER 1 – Literature Review
1.1 Introduction
At the center of milk production lays the secretory mammary epithelial cell (MEC). This
cell is responsible for the production and secretion of all milk components that are relied
upon to solely nourish newborn offspring of the Class Mammalia. With changing stages
of the reproductive life of the female mammal, the role of the mammary gland also
changes. As the gland prepares for lactation the MEC population must expand and
develop into cells capable of the metabolic power necessary to fulfill their function. The
hormonal cues of puberty, pregnancy and lactation influence the development and
differentiation of the MEC into a milk producing phenotype. Though the changing
hormonal cues playing a role in the development of the mammary gland are well
documented, the resulting molecular signals are less understood. This topic is being
heavily investigated as better understanding of these underlying mechanisms can lead to
improvements in the dairy industry, breast feeding, and even prevention and treatment of
breast cancer.
Approaches to the study of biological science fields, such as mammary development,
have shifted to the evaluation of whole systems and networks of data at once by
performing experiments that allow discovery of new molecules and processes instead of
confirmation or refutation of theories about a specific pathway. The broad topics of study
focused on whole systems have become to be known as the “-omics.” These studies allow
the discovery of new investigative topics and the ability to see more factors interacting in
a system at one time. These methods require collaboration with technology-related fields
in order to produce computer systems able to manage and analyze the large and complex
1

	
  
datasets being generated. An interdisciplinary approach is recognized as essential and is
being implemented as shown by the emerging field of bioinformatics.
This review will cover the stages of development of the mammary gland, the mechanisms
behind its changing phenotype that have been discovered thus far, and importance of the
emergence of interdisciplinary studies in advancing understanding of systems such as this
one.
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1.2 The Mammary Gland
1.2.1 Anatomy of the fully developed gland
A unique characteristic of the mammary gland is its ability to repeatedly undergo
functional differentiation and involution to quiescence throughout the sexually productive
period in the life of the female mammal. The majority of the gland’s development occurs
beginning at puberty, but it is not fully developed and functional until the female
experiences pregnancy and lactation. The gland is comprised of two tissue compartments:
the epithelial parenchyma and the stroma. This section describes the anatomy and basic
function of these compartments as they exist in a fully developed mammary gland in
order to provide understanding of all structures and cells that can be found in the gland.
The following section will walk through specifics for each stage of mammary gland
development.
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1.2.1.1 Parenchyma
The parenchyma is the tissue of the gland that is responsible for the synthesis, secretion
and transport of milk to the offspring. Its overall structure resembles a tree branching into
the bed of the stromal tissue of the gland. This branching structure varies slightly among
species, but its general components and functions remain the same.

1.2.1.1.1 The alveolus
When following a drop of milk through the mammary gland from its origin of production
to its expulsion into the mouth of the offspring, the journey begins in a structure called
the alveolus, or acinus. Alveoli are small spherical structures made up of a lumen
surrounded by two different layers of distinct cell types and are often clustered in
bunches called lobules. Looking from the inside of the lumen, secretory luminal epithelial
cells are seen lining the inner layer of the alveolus. The secretory MEC are cuboidal to
columnar in shape and are connected to each other by tight junctions, allowing strict
control over everything that enters or leaves the lumen of the alveolus. These tight
junctions change in permeability based on different stimuli, but are impermeable during
lactation to prevent paracellular leaking in either direction in order to maintain milk
composition and to allow storage between times of nursing (Nguyen and Neville, 1998;
Mepham, 1983). These are the functional cells of milk production; secretory MEC are
responsible for all synthesis and transport of the necessary components into the alveolar
lumen to create the final product known as milk. The processes underlying synthesis of
these different milk components by the secretory MEC will be discussed later in this
chapter.
4

	
  
Unseen from the inside, but sprawled around the outside of this layer of secretory cells in
a pattern resembling a woven basket is the branching basal myoepithelial cell layer.
Lactating rat mammary glands were found to have 4-6 myoepithelial cells per alveolus
with each cell having 8-10 terminally branched processes, allowing encompassment of
the structure (Nagato et al., 1980). These cells resemble smooth muscle cells in their
filament profile and have the ability to contract in response to the hormone oxytocin,
causing them to compress the alveolus and force milk out of the lumen into the
connecting duct (Emerman and Vogl, 1986; Nagato et al., 1980). Myoepithelial cells
contain gap junctions between each other, most likely for coordination of this contraction
(Mepham, 1983).
Though its size may vary, the alveolus is present and similarly structured in mice, cattle
and humans and performs the same essential functions.

1.2.1.1.2 The ductal system
When the signal is given by oxytocin, the alveolar myoepithelial cells contract and the
milk is pushed from the alveolar lumen into the ductal system. The ductal system
transports the milk unaltered from the site of production to the site of ejection. Smaller
ducts collect milk from the alveolar lumen and transport it to progressively larger ducts,
eventually culminating in a single collecting duct that terminates at an orifice in the
nipple or teat (Mepham, 1983). Arrangement, number and size of the ducts vary with
species, but the microstructure is conserved.
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The ducts transporting the milk through the gland are very similar to the alveolus in
cellular composition. Cuboidal to columnar epithelial cells resembling the secretory MEC
line the ductal lumen, but these epithelial cells do not produce and secrete milk
components like those of the alveoli (Hassiotou and Geddes, 2013). Tight junctions are
still present and very important in the ductal lumen in order to maintain the pressure
needed to transport and eject the milk from the gland as well as prevent any movement of
material in and out of the ductal system through the paracellular route (Nguyen and
Neville, 1998).
A myoepithelial layer also surrounds this layer of non-secretory luminal epithelial cells.
Unlike the branching basket-like pattern of the alveolar myoepithelium, the cells of the
duct are long and narrow in shape, arranged parallel to the direction of milk flow through
the duct. Contraction of these cells results in a decrease in length and increase in diameter
of the duct, allowing the quick movement of a larger volume of milk through the gland
and to the nipple for ejection in response to the oxytocin cue (Emerman and Vogl, 1986).
Ductal microstructure and function is conserved greatly across species, but patterns of
branching and numbers of ducts vary among them. Female mice have only one ductal
opening at each nipple. Each duct divides into secondary ducts and forms a branching
tree network ending in clusters of alveoli, but all milk produced in each gland culminates
into the single lactiferous duct leading to each nipple (Cardiff and Allison, 2012). Like
the female mouse, the cow has a branching epithelium draining into only one lactiferous
duct leading to each teat. While the mouse and the human have ducts with relatively
constant diameter leading up to the point of milk ejection and little room in the way of
milk storage, the cow has an enlargement in the diameter of the duct where the milk from
6

	
  
all the branches collects prior to the duct orifice. This enlarged portion of the duct is used
for milk storage and is called the gland cistern (Reece, 2009). Unlike the cow and mouse,
the human has multiple ducts associated with a single mammary gland reaching the
surface of each nipple. Each duct leads to a completely separated branching lobe of the
mammary gland divided by fibrous stroma. The number of ducts and lobes per human
breast varies greatly among individuals, where the most recent data reports an average of
nine fully functional lobes with ducts opening to the surface (Ramsay et al., 2005;
Gooding et al., 2010; Hassiotou and Geddes, 2013). While they vary in organization, the
ducts for all three have their individual benefits and satisfy the purpose of the ductal
system, which is transport of the final unaltered milk product from the site of production
to the site of ejection.

1.2.1.1.3 The teat
After its journey through the ducts, the milk arrives at the nipple or teat where the
offspring can latch on and consume the ejected milk from the gland. Though not truly
considered part of the parenchyma, the nipple plays a large role in the final step of milk
delivery to the young and warrants discussion alongside the parenchymal components.
This region is characterized by an outside covering of hairless epidermis formed around
the orifice of the lactiferous duct, or ducts (Koyama et al., 2013). Smooth muscle is also
found in the region near the epidermis and near the ducts and is important for the
protrusion of the nipple to allow latching of offspring and for sphincter like function to
prevent milk escaping from the teat between times of nursing (Hassiotou and Geddes,
2013).
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Not only is this the site of milk expulsion and structurally important for the delivery of
milk to offspring, but it is the site of afferent nerve endings that influence every event in
the process of nursing young. Stimulation of these nerves causes release of oxytocin
which cues the contraction of myoepithelium, as well as the release of prolactin, whose
effects will be further covered later in this chapter (Koyama et al., 2013).
The nipples, or teats, of mammals vary in number and shape among species determined
by the need of the offspring. Female mice have ten total nipples, each associated with its
own mammary gland. They are positioned in pairs along the ventral portion of the mouse
with three in the pectoral region and two in the inguinal region (Koyama et al., 2013).
Cows have four total teats, also each associated with its own gland. They are positioned
in the udder as two pairs, located in the inguinal region of the cow (Reece, 2009).
Humans have only two nipples, each also associated with its own gland. As mentioned
previously, each gland consists of multiple completely separated lobes that have
individual openings at the same nipple, but they are still collectively considered a single
gland. Position of the human glands exists as one pair in the pectoral region (Koyama et
al., 2013).
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1.2.1.2 Stroma
Parenchyma may produce and secrete and transport the milk components, but without the
stroma the mammary gland would not be able to fully develop and carry out its intended
function. As has been covered several reviews, stromal tissue of the mammary gland
provides structural support for glandular tissue and delivers essential growth factors and
hormones that direct the development and maintain the structure and function of the
gland (McCave e al., 2010; Hovey et al., 1999). Components of the stroma include the
extracellular matrix (ECM), adipocytes, immune cells, fibroblasts, and the endothelium.
Each of these components varies in abundance and organization among species, but they
all play an important role in the development and function of the mammary gland.

1.2.1.2.1 Extracellular matrix
The ECM is not a cellular component itself but is essential for and isproduced by the cells
of the mammary gland. The ECM is composed of macromolecules secreted by the cells
of the connective tissue and MEC. Glycosaminoglycan and fibrous proteins such as
collagen, elastin, and laminin are the major components forming the matrix. The
composition and organization of the matrix is constantly in flux and maintained by the
cells of the stroma in response to released factors as well as mechanical stress (Alberts et
al., 2002). Different regions of ECM are composed of different proportions of the
mentioned proteins because of the role it needs to fill and the cell types present that are
responsible for secreting the components (Maller et al., 2010). In humans and cows the
ECM, along with fibroblasts, creates a thick fibrous layer separating the adipose tissue
and parenchyma of the mammary gland and is extensive between and within the lobules
9

	
  
in these species to help provide extra support and maintain the form of these glands due
to their size and placement (Hovey et al., 1999).
In addition to providing structural support to the parenchyma by allowing attachment and
stability, the ECM has also been implicated in apoptosis, proliferation, branching, cell
polarity and differentiation. The proteins of the ECM serve as signaling molecules in
signal transduction pathways as well as mechanotransducers by connecting the ECM to
the cytoskeleton of the cells (Butcher et al., 2009). Growth factors and cytokines are also
bound to the proteins of the ECM, whereby it can serve as a reservoir for the
sequestration of signaling molecules in specific locations for different purposes such as
directing ductal growth during development or recruiting immune cells which are present
and active in all stages of development (Maller et al., 2010).

1.2.1.2.2 Immune cells
Cells of the immune system are present and active throughout mammary development
and function. Branching morphogenesis, terminal end bud (TEB) formation and ductal
outgrowth are impaired without the presence of mast cells, macrophages and eosinophils.
Lilla and Werb demonstrated decreased cell proliferation and impaired mammary
development in mice deficient in or lacking mast cells (2010). Mast cells were seen
concentrated near or ahead of the TEB in developing murine mammary glands. It was
determined that mast cells most likely function in development by contribution of some
component released during degranulation. Though uncertainty surrounding their exact
function in development persists, it is speculated that released proteases or other factors
aid in angiogenesis, remodeling the ECM or activating other proteases. Macrophages and
10

	
  
eosinophils are also known to exist in close proximity to the TEB during branching
morphogenesis and ductal outgrowth and are necessary for normal development.
Depletion of these cells resulted in the complete absence of TEBs and stunted ductal
outgrowth (Gouon-Evans et al., 2002, 2000). Macrophage-specific depletion showed
defective TEB formation and reduced ductal outgrowth indicating a role in these
processes, probably accomplished by phagocytic activity and trophic factor release
(Gouon-Evans et al., 2000). Eosinophil-specific depletion resulted in decreased number
of branches indicating a role in branching of the ducts, possibly carried out by release of
TGF-β or other factors (Gouon-Evans et al., 2000).
Development during pregnancy and lactation also requires the influence of immune cells.
A need for colony stimulating factor 1 (CSF-1) has been described in the development of
a properly functioning lobulo-alveolar system; in addition to a reduced number of
macrophages, CSF-1 deficient mammary gland resulted in the inability to switch to the
lactating phenotype, suggesting a possible role for macrophages in this process (Pollard
and Henninghausen, 1994). In addition to the development, plasma cells are recruited to
the mammary gland during lactation and are essential for production of antibodies that
are incorporated into the milk by the epithelial cells. IgA is the primary antibody
produced in the mammary gland and is found in the milk of mice, cattle and humans.
Other antibodies are transferred into the milk from the blood including the main antibody
present in bovine colostrum, IgG (Weisz-Carrington et al., 1977; Hunziker and
Kraehenbul, 1998; Bourges et al., 2008). Production and delivery of these antibodies
through the milk is essential to the first defense of the offspring.
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In addition to the developmental functions mentioned above, the immune cells of the
mammary gland are also fulfilling their most well known function of scouting the gland
for infiltrators and keeping the tissue and the milk free from infection (Stelwagen et al.,
2009).

1.2.1.2.3 Adipocytes
The mammary gland of the mouse contains a far higher proportion of adipocytes than the
cow or human (Hovey et al., 1999). Many of the studies investigating the roles of these
adipocytes have been performed with mice; applying conclusions from results across
species should be implemented with caution. Though previously thought to play little role
in the development and function of the mammary gland, essential functions of the
mammary adipocytes have been unveiled, as nicely outlined in a recent review (Hovey
and Aimo, 2010). Adipose tissue has been acknowledged as an indispensable component
of the mammary stroma.
Of the many roles the adipocytes play in the gland, one is provision of nutrient
components to the epithelial cells to aid in milk production during lactation. Depletion of
the fat stores in adipocytes in the lactating mammary gland has been observed and is
believed to provide fatty acids to the epithelium (Elias et al., 1973; Clegg, 1981), though
it is believed that only a small proportion of the fatty acids needed by the MEC are
supplied by the adipocytes (Neville et al., 1998). The rest would be synthesized in the
MEC or delivered through the blood from diet or other fat deposits. Adipocytes
themselves have also been found to release lipoprotein lipase into the circulation of the
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mammary gland to breakdown TAG from the blood into fatty acids for the parenchyma to
utilize to for milk component synthesis (Jensen et al., 1994).
In addition to providing nutrients, adipocytes have the ability to produce a multitude of
paracrine and endocrine factors including growth factors and hormones. Among these
molecules produced is the hormone prolactin, which was previously thought to have the
sole production center in the anterior pituitary gland. This has been found true in humans
and mice, though its autocrine or paracrine role has not been confirmed as necessary
(Zinger et al., 2003). Potential for estrogen production in the mammary adipose due to
expression of aromatase has also been found, which was shown to be prolactin-inducible
in bovine mammary adipose cultures (Feuerrman et al., 2009). Many growth factors are
also produced by the adipocytes of the mammary gland such as insulin-like growth factor
1 (IGF-1), transforming growth factor-β (TGF-β), and vascular endothelial growth factor
(VEGF), which take part in development of the glandular epithelium, response to
hormone activation, and development of the mammary vasculature, respectively.

1.2.1.2.4 Fibroblasts
Fibroblasts are the major cells of connective tissue and secrete the components making
up much of the ECM, including production of components in the basement membrane
such as laminin, nidogens, and collagen. The ECM, as mentioned above, is essential for
support of the glandular tissue and proper development and function of the mammary
gland; presence of some of these components has been shown necessary for polarization
and differentiation of mammary epithelium (Luhr et al., 2012). Fibroblasts are also
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responsible for the secretion of growth factors and matrix metalloproteinases that play
roles in multiple stages of mammary development (Simian et al., 2001).

1.2.1.2.5 Endothelium
Vascularization of the mammary gland is present throughout the development of the
organ, with vast expansion occurring during pregnancy and regression at involution
(Andres and Djonov, 2010). Endothelial cell precursors are recruited from the bone
marrow or created from resident pluripotent stem cells in the tissue to form and remodel
microvasculature during pregnancy by the influence of hormones such as estrogen
(Kabmeyer et al., 2009; Cid et al., 2002). During pregnancy and lactation, the
endothelium is organized in capillaries enveloping each individual alveolus and the
capillaries become more permeable to enable efficient nutrient transfer (Djonov et al.,
2001; Abdul-Awal et al., 1996). In humans it was found that relatively large and few
sinusoidal shaped capillaries encircle each alveolus to allow slow movement of blood and
ensure transport of essential nutrients and hormonal signals to the alveolar cells
(Naccarato et al., 2003). The major known molecule playing a large role in vasculature
forming and remodeling during pregnancy is VEGF, which has been shown to be
inducible by estrogen and is secreted by the epithelium and other cells of the stroma
(Rabbany et al., 2003; Hovey et al., 2001; Andres and Djonov, 2010).
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1.2.2 Developmental events and stages of the mammary gland.
1.2.2.1 Pubertal growth
Until puberty the mammary gland undergoes isometric growth, at which time females
experience allometric growth of the gland in response to changing hormone levels. A rise
in gonadotropin releasing hormones from the newly mature hypothalamic-pituitarygonadal axis at the onset of puberty causes production of ovarian hormones (Howlin et
al., 2006; Plant and Barker-Gibbs, 2004). The production and release of these hormones
cause the outgrowth of the mammary ductal tree into the surrounding stroma.
In the rodent, highly proliferative bulb-shaped structures called terminal end buds (TEB)
are formed in the parenchyma and lead the ducts as they extend through the existing fat
pad. The TEB is made up of different layers of epithelial cells with the outermost layer
being made up of a stem cell population referred to as the cap cells. These cells line the
outside of the TEB from the leading edge into the neck region of the structure and are
continuous with the differentiated myoepithelial layer of the duct, as these cap cells
eventually give rise to the myoepithelium (Richert et al., 2000; Williams and Daniel,
1983). At the trailing edge of the TEB, the differentiated myoepithelial cells produce
basement membrane surrounding the duct while the fibroblasts of the fat pad secrete
other components of the stroma surrounding the membrane (Daniel and Silberstein, 1987;
Williams and Daniel, 1983). This outside layer of cap cells surrounds several layers of
epithelial cells referred to as the body cells. These cells eventually become the ductal
epithelial cells (Daniel and Silberstein, 1987). The innermost layer of body cells
undergoes apoptosis in order to form the lumen of the duct; in fact, the levels of apoptosis
observed in the TEB during ductal expansion (11.3%) are higher than observed levels in
15

	
  
any other stage of mammary development, including involution (4%; Quarrie et al., 1995;
Humphreys et al., 1996). Bifurcation of the TEB allows for full outspread to the edges of
the fat pad. Though it is difficult to study pubertal development of the mammary gland in
humans, it appears that there are also end bud-like structures leading the expansion of the
ducts during this period of outgrowth, though cap cells like in rodent TEB have not been
identified (Howard and Gusterson, 2000). Bovine mammary glands are a bit different in
their structure and timing of outgrowth with a central, solid epithelial cord surrounded by
5-10 ductal outgrowths called a terminal ductal unit (TDU) that influence allometric
growth prior to puberty. The whole unit invades the stroma together and the lumen does
not appear to be created by high levels of apoptosis as has been determined in the rodent
gland (Capuco and Ellis, 2005). Hormone levels, the hormone receptor profile of
different cell types, and growth factors within the mammary gland dictate these patterns
of growth.
Among several hormones affecting this surge in growth, estrogen (E) has the primary
effect. Estrogen receptor α (ERα) is essential for ductal outgrowth during pubertal
development, while ERβ doesn’t seem to play a role (Mallepell et al., 2006). Presence of
ERα in the mammary epithelium was shown to be necessary for this development while
its presence in the stroma did not affect the ductal outgrowth (Mallepell et al., 2006).
Cells devoid of ERα were shown to proliferate - in fact, in rodents and humans
proliferating cells rarely contain steroid receptors (Clarke et al., 1997; Russo et al., 1999).
It is thought that E exerts its effects in a paracrine manner, acting only on a subset of cells
in the mammary epithelium which then produce and secrete additional factors that act on
other epithelial cells directly, or on stromal cells, also causing release of growth factors
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that would influence epithelial outgrowth. Amphiregulin (AREG) is thought to be the
molecule responsible for mediating this response to E. Its receptor, epidermal growth
factor receptor (EGFR), is necessary in the fat pad for normal development and stromal
cells secrete growth factors in response to this molecule (Wiesen et al., 1999; Sternlicht et
al., 2005). Though the increase of ovarian E at puberty is of utmost importance, it is well
documented that the presence of a certain pituitary hormone is essential for ductal
outgrowth as well (Sternlicht, 2005).
Growth hormone (GH) is also necessary for ductal outgrowth during puberty. It is
thought to influence the formation of the TEB that begins invading the mammary stroma
(Kleinberg, 1997). Growth hormone is produced by the anterior pituitary and acts on the
stroma of the mammary gland to induce expression of ER and insulin-like growth factor
1 (IGF-1). This locally produced factor then acts on the MEC to induce formation of
TEB, and proliferation and outgrowth of the ductal system, which without the ability to
respond to IGF-1 does not occur (Walden et al., 1998; Wood et al., 2000; Hadsell and
Bonnette, 2000). Estrogen acts synergistically with GH and IGF-1 to allow proper
outgrowth and development of the pubertal gland (Kleinberg, 1997; Ruan et al., 1995).
Far less credit has been given to other hormones and steroid receptors, and while E and
GH remain to be considered the hormones most involved in ductal outgrowth during
puberty, a few others have been implicated in the regulation of this process as well and
should be given an honorable mention. Though little evidence has been found for a large
role for progesterone (P) in the pubertal mammary gland, it has been shown that pubertal
branching is delayed when PR is antagonized (Shi et al., 2004) and it was recently shown
that progesterone might also work through AREG to aid in ductal growth and branching
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in the pubertal gland (Auperlee et al., 2013). Though these new functions are being
uncovered, the largest role P plays still occurs during pregnancy. Knockout of the
glucocorticoid receptor has also caused abnormal development during puberty, though
this is difficult to properly study because of the necessity of transplanting mammary
tissue from the embryo into fat pads due to lethal consequences of the deletion (KingsleyKallesen et al., 2002). In contrast to these previous two, the vitamin D3 receptor (VDR)
seems to aid in the repression of ductal outgrowth. Mice with VDR knockouts displayed
accelerated outgrowth and ductal branching during puberty (Zinser et al., 2002). It is
speculated that E causes transcription and translation of VDR, which appears to
antagonize the proliferation of the epithelium, possibly through the regulation of the ER
itself (Byrne et al., 2000; Welsh et al., 2003; Howlin et al., 2006).
In addition to hormones and steroid receptors, additional locally produced growth factors
much like IGF-1 also play a role in directing and regulating mammary ductal outgrowth.
Due to the focus of this review, these factors will not be discussed but their important
roles in development are continuously being discovered. These include factors such as
epidermal growth factor, TGF-β, and hepatic growth factor. This list is not exhaustive
and full understanding on their effects of the gland and its development has not been
achieved. While it is clear that E and GH drive the outgrowth and development of the
epithelium, the regulation of proper growth and development during puberty is optimal
when many different hormones, receptors and factors are present and working together in
harmony.
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1.2.2.2 Virgin adult
Terminal end buds of the developing ducts of the mammary gland have reached the
borders of the fat pad and regressed to non-motile units by the end of puberty. Although
full development and capacity to secrete milk components does not occur until
pregnancy, changes in the gland occur with every estrous cycle. Tertiary side branches
begin to expand within the stroma between developed ducts and acini and show
development and regression with the cyclic production of different ovarian hormones
(Daniel and Silberstein, 1987). In both rodents and humans the mammary epithelium
cycles through stages of proliferation, differentiation and apoptosis that mirror the
hormone changes through the estrous cycle. Peak proliferation of MEC occurs during
metestrus and diestrus-1 in rodents and the equivalent, late luteal phase, in humans
(Schedin et al., 2000). Peak differentiation has been seen during the same time period of
luteal phase and metestrus/diestrus-1, as measured by beta-casein and whey acid protein
mRNA levels throughout the cycle (Schedin et al., 2000). Lastly, apoptosis levels were
elevated and suppressed at similar points in the cycles of rodents and humans. Apoptosis
was found to be much more variable than proliferation but was seen to be suppressed
during times of peak proliferation and increased during proestrus and diestrus-2 (Schedin
et al., 2000). Although they are continuously developing, the alveolar development never
reaches near the level of differentiation of pregnancy.
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1.2.2.3 Pregnancy
Though developing and regressing with each estrous cycle during the gland’s nulliparous
adult existence, the gland does not begin down the path of full development until
conception. Prior to conception, the gland has branched via TEBs to the ends of the
mammary fat pad and lacks only the extensive side branches and alveoli that are seen in a
lactating mammal. After conception, the ovum implants in the uterus and causes
hormonal changes that alert the body of pregnancy. In the human, cells that are destined
to be the placenta begin producing human chorionic gonadotropin (hCG), which is
responsible for the maintenance of the corpus luteum and its continued P and E secretions
during early pregnancy. In rodents, prolactin (PRL) secretions are responsible for this
early corpus luteum maintenance (Neville et al., 2002). The lengthened survival of the
corpus luteum allows for its further production of P and E, which cause side branching
and alveologenesis in the mammary gland and production of PRL from the anterior
pituitary, respectively. At mid pregnancy placental lactogen takes over this role of corpus
luteum maintenance in rodents while in humans, the placenta itself begins to produce the
required hormones for maintenance of pregnancy and mammary development (Neville et
al., 2002). While E induces expression of PR and PRLR in the mammary epithelium as
well as production of PRL from the anterior pituitary, P and PRL work together to
prepare for lactation. Both P and PRL each induce the expression of the other’s receptor
and individually work in a paracrine fashion, recruiting other factors to signal for ductal
side branching, proliferation and MEC differentiation (Brisken et al., 1999; Edery et al.,
1985; Sakai et al., 1979).
Progesterone acts through progesterone receptor B (PRB) to elicit responses related to
20

	
  
mammary development; it has been found responsible for side branching and mitotic
activity of the epithelium during pregnancy (Brisken et al., 1998). As the majority of
proliferating cells are PR negative, the possible paracrine activation of these cells has
received much attention. Investigations into this topic are far from over, but candidate
pathways have been proposed. Wnt-4 was the first proposed mediator of P action in the
mammary gland. Brisken and colleagues showed that P induces Wnt-4 expression during
early pregnancy and that it is capable of causing side branching in the mammary
epithelium (2000) and Ramamoorthy and colleagues showed that Wnt-4 is a direct
transcriptional target of PR (2010). Whether it causes a response in neighboring cells
remains to be determined. Receptor activator of NF-κB-ligand (RANKL) and its
receptor, RANK, are the strongest current candidates for the paracrine mediators of P
action. Investigation into this factor began when Fata and colleagues discovered that mice
lacking RANKL or its receptor failed to develop alveolar structures during pregnancy
(2000). Since this discovery, RANKL has been found to be stimulated by P as well as
have the ability to induce Elf5 expression (Beleut et al., 2010). This was particularly
interesting because Elf5 has been found necessary for successful alveolar morphogenesis
and lactation (Oakes et al., 2008; Choi et al., 2009). Elf5 and PR expression were found
to be mutually exclusive so Lee and colleagues proposed that RANKL acts as a paracrine
mediator for P in order to induce Elf5 (2013). RANKL is also thought to mediate a
proliferation response to P in neighboring PR negative cells by inducing cyclin D1
expression (Fernandez-Valdivia et al., 2009). As this information is very recent, there is
still much to learn about the intracellular signaling resulting in developmental changes in
response to PR activation, but light has been shed on the role P has on development
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during pregnancy and possible mediators of this response. In addition to P, PRL has an
equally important role during pregnancy.
Prolactin and its receptor are necessary for normal alveolar development, full
differentiation of the mammary epithelium, and successful lactation following parturition
(Ormandy et al., 1997). Prolactin binds the prolactin receptor (PRLR), which activates
the Janus kinase/signal transducer and activator of transcription (JAK/STAT) and protein
kinase B (PKB/Akt) pathways. Through these pathways PRL affects structural
development of the mammary gland during early pregnancy and production of milk
components during late pregnancy and lactation. Signal transducer and activator of
transcription 5 (STAT5) is a transcription factor in the PRLR/JAK/STAT pathway whose
phosphorylated state can activate transcription of several genes involved in processes
important for epithelial cell differentiation such as polarity establishment, epithelial cellcell and epithelial-stromal interactions, and milk protein production (Oakes et al., 2006).
Alveolar defects are seen in STAT5-/- mice and complete absence of alveolar structures
and beta-casein is seen in PRLR-/- mice after full term pregnancy (Liu et al., 1997;
Brisken et al., 1999). Much overlap has been seen in the intracellular signaling cascades
that result from PR and PRLR activation. As stated above, PR can induce expression of
Elf5 through RANKL. Elf5 seems to have the ability to induce expression of STAT5 and
inhibit members of the suppressor of cytokine signaling (SOCS) family, which are
inhibitors in the JAK/STAT phosphorylation pathway. Induction of Elf5 expression
would both cause production of STAT5 and allow increased phosphorylation of this
molecule by JAK in the PRLR/JAK/STAT pathway (Choi et al., 2009). There are
conflicting studies that report whether or not PRLR might also induce RANKL through
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the JAK/STAT pathway and play a role in activating Akt pathways that decrease
apoptosis and delay involution (Srivastava et al., 2003; Brisken et al., 2002). Another
molecule speculated to play a role in PRLR signaling is IGF-2. Activated PRLR induces
expression of IGF-2, which in turn causes activation of cyclin D1 and MEC proliferation
(Hovey et al., 2003; Brisken et al., 2002). Though details still need to be clarified and
confirmed, it has been revealed that both PRL and its mediators are required for normal
alveologenesis and roles for these individual mediators are starting to be uncovered.
Both P and PRL are necessary for the massive proliferation and differentiation seen in the
beginning stages of pregnancy to prepare for mass production of milk components, but
their roles shift in the later stages of pregnancy prior to parturition and lactation.
Progesterone suppresses milk secretion during this time while PRL leads to STAT5
induction of milk component expression in the differentiating cells. The removal of the
progesterone signal along with high levels of PRL is what eventually allows for lactation
(Neville et al., 2002; Anderson et al., 2007). During the withdrawal of P in the MECs,
colostrum is produced with the transport of immunoglobulin and transferrin in addition to
other milk components prior to parturition (Neville et al., 2001).
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1.2.2.4 Lactation
Due to the influences of PRL and P during pregnancy, the mammary tree is complete at
the time of initiation of lactation. Primary ducts and side branches have filled the fat pad,
which now contains large, fully developed alveoli that are already producing milk
components (Anderson et al., 2007). Initiation of lactation occurs around the time of
parturition in response to dropping levels of P. In rodents and cows, the level of P sharply
decreases and PRL levels spike just prior to parturition, so they are fully lactating when
the offspring are born. The level of P in humans does not fall until after parturition, at
which point it drops 10-fold in 4 days. The concentration of PRL is already high in
humans at parturition as it continuously increases during pregnancy (Neville et al., 2001;
Anderson et al., 2007). The placenta and corpus luteum are no longer producing P; the
main players from the endocrine system are now the pituitary hormones PRL and
oxytocin with the help of a few others to drive metabolic processes (Fendrick et al.,
1998).
When stimulated during suckling, the nerve endings at the tip of the nipple send signals
to the central nervous system to order the release of hormones including PRL and
oxytocin from the pituitary gland (Koyama et al., 2013). Prolactin acts on the secretory
MEC to stimulate continued milk production and secretion while the oxytocin causes
contraction of the myoepithelium leading to the transport of the milk from the alveoli,
travel through the ducts, and ejection to the offspring. As long as suckling and initiation
of this mechanism is continued, oxytocin continues to eject the milk and PRL elicits its
production. Though PRL is thought to be the main hormone of milk production, other
hormones have been implicated as having a role in the process.
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There has been some speculation about the roles of insulin, cortisol, thyroid hormone and
growth hormone (GH) in governing lactation alongside the influence of PRL. Though
initially thought to help the mammary gland increase milk production directly, insulin
levels were found to be low in most lactating animals, which is thought to aid the
mammary gland in a different way – by discontinuing normal storage mechanisms and
help mobilize energy stores from other parts of the body to provide the mammary gland
nutrients for milk production (Vernon, 1989; Neville et al., 2002). Although low levels
appear to help mammary milk production, the presence of some insulin is necessary for
transcription of milk proteins (Trott et al., 2012). Cortisol appears to be elevated in dairy
cattle and rodents during lactation, but often at low levels in lactating women. Since it is
responsible for maintaining blood glucose it has been speculated that this is the case due
to energy store depletion and nutrient availability during lactation of the different species
rather than a direct effect on the mammary gland (Neville et al., 2002; Feng et al., 1995;
Butte et al., 1999). Thyroid hormone has been shown to be important for the MEC
responsiveness to PRL and GH, but has not gained much attention in the recent years
(Capuco et al., 1999). Receptors for GH have been found on the mammary epithelium
and in the stroma in both types of animal, so it has the ability to act directly on the MEC
and can influence milk production by causing expression of IGF-1 both in the mammary
stroma and the liver, which can then act directly on the MEC. Growth hormone has
proven to be more influential on ruminant lactation after the beginning stages than it
appears to be in rodents (Vernon, 1989). Exogenous GH increases milk yield in cattle,
which has led to its controversial use in the dairy industry for increased product (Bauman
and Vernon, 1993; Neville et al., 2002). Inhibition of GH in rodents has been shown to
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slightly reduce milk yield (Flint and Vernon, 1998), but even though GH and PRL have
very similar receptors and elicit similar effects, PRL is still considered the most
influential of the hormones in milk production. Prolactin inhibition at the onset of
lactation greatly affects milk production in many species, including cattle (Karg and
Schams, 1974; Neville et al., 2002). Though the detailed intracellular signaling involved
in the influence of PRL on milk production is not well known, its role in milk protein
synthesis, production of lipogenic and glycolytic enzymes, transporter expression, and
lipid droplet formation has been shown and is being continuously investigated (Rudolph
et al., 2011). Phosphorylated STAT5 and Akt1 are thought to play major roles in the
transcription of many of the genes involved in synthesis of milk components (Anderson
et al., 2007; Liu et al., 1997) and recent links between STAT5 and Akt1 have been found,
though the specifics of these links are variable (Chen et al., 2010; Creamer et al., 2010;
Chen et al., 2012). One link between the two showed that STAT5 induced expression of
Akt1, which aided in cell survival and delayed involution during lactation. The specifics
of all the intracellular mechanisms behind inducing the production of milk are still being
investigated, but the components of milk and the metabolism of these products are
relatively well understood.
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1.2.2.5 Synthesis of milk components
Milk contains all of the necessary nutrients for the offspring to survive and grow. These
include carbohydrate primarily in the form of lactose, lipids primarily in the form of
acylglycerol, a variety of proteins including the major milk proteins, caseins and whey
proteins, vitamins and minerals, and water. There are a huge variety of molecules present
in milk so only the major constituents will be further discussed. All of these components
are synthesized and secreted, or transported from the blood to the milk, by the secretory
MEC lining the lumen of the alveoli. Specifics of the synthesis and secretion of these
components including a mention of any known hormonal influence on their regulation
will be covered in the following text.

1.2.2.5.1 Lactose synthesis
Lactose is the primary carbohydrate found in the milk of most mammals and is the major
osmotic constituent responsible for drawing water into the final product of milk. Water
makes up the majority of milk, with all other components being dissolved or suspended
in it. Lactose concentration is rather constant within a species and relatively constant
across species when compared with other milk components. In humans, cattle and mice
lactose makes up approximately 7%, 5%, and 2.5% of milk, respectively (Jenness, 1974;
Gors et al., 2009; Johnson et al., 2001). Synthesis of lactose is unique to the secretory
MEC and is carried out by the enzyme lactose synthetase. Lactose synthetase is made up
of galactosyltransferase and its cofactor, α-lactalbumin, which is also a secreted milk
protein. Expression of both of the enzyme’s subunits can be induced by PRL and there is
evidence that insulin is necessary for expression of α-lactalbumin (Palmiter, 1969;
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Turkington et al., 1968; Rosen et al., 1999). This enzyme catalyzes the reaction between
UDP-galactose and glucose to create lactose and UDP (Kuhn et al., 1980). As even UDPgalactose is derived primarily from glucose in the secretory MEC, glucose is necessary
and in high demand for lactose synthesis (Faulkner and Peaker, 1987). A glucose
transporter independent of insulin regulation is responsible for maintaining a high
glucose concentration within the cell as well as allowing glucose into the Golgi
compartment to support lactose synthesis; this transporter is GLUT1 and its expression is
increased under the influence of PRL during lactation. Its location on the Golgi
membrane is unique to the secretory MEC (Nemeth et al., 2000; Anderson et al., 2007).
Glucose is in high demand in the secretory MEC during lactation for the synthesis of
milk components other than just lactose.

1.2.2.5.2 Lipid synthesis
Triacylglycerol (TAG) makes up 98% of the fat in milk (Anderson et al., 2007; Jenness,
1988), while total fat in milk varies among species ranging from nearly 0% up to around
50%. Humans and cattle produce milk with an average of 4% fat while mice produce
milk with approximately 20% fat content (Neville and Picciano, 1997; Gors et al., 2009;
Johnson et al., 2001). Milk fat content can also largely vary within species dependent on
body condition, diet, and stage of lactation (Neville and Picciano, 1997). Triacylglycerol
is made up of a glycerol backbone esterified to three fatty acids (FA). Fatty acids are
either transported into the cell from adipose stores, supplied by diet, or synthesized de
novo in the MEC from glucose, amino acids, or in the case of ruminants, acetate.
Composition and source of FA can also vary with species, diet and body condition. Long
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chain FA are typically delivered to the cell by albumin carriers and lipoproteins or in the
form of TAG from the diet or lipid stores of the body via the blood in which it is broken
down by lipoprotein lipase into FA and glycerol before being taken up into the MEC.
Medium chain FA are synthesized in the MEC from glucose in nonruminants, or acetate
in ruminants, or amino acids in both and their levels are reduced if high dietary fat is
present (Neville and Picciano, 1997; Anderson et al., 2007). Unlike in nonruminants,
short chain FA are synthesized de novo and found in ruminant milk (Knight and Beever,
1994; Neville and Picciano, 1997). Glycerol-3-phosphate is used as the glycerol
backbone to which the FA attach and form TAG. It is either transported into the cell from
the blood in the form of glycerol, which is then phosphorylated, or it is synthesized from
dihydroxyacetone phosphate (DHAP), which originates from glucose (Salway, 1994;
Anderson et al., 2007). Glucose also contributes to NADPH production. Fatty acid
synthesis requires NADPH as a reducing agent whether they are being synthesized from
acetate or glucose precursors. NADPH can be generated through different pathways that
vary with species. Non-ruminants can generate NADPH through the malate/pyruvate
pathway, the isocitrate pathway, or through the pentose phosphate shunt (PPS). The
conversion of malate to pyruvate by malate dehydrogenase generates NADPH and allows
pyruvate to re-enter the TCA cycle. Ruminants lack this ability as they have very low
malate dehydrogenase and citrate lyase activity. Ruminants do have high isocitrate
dehydrogenase activity and NADPH can also be generated by the conversion of isocitrate
to α-ketoglutarate by this enzyme (Ingle et al., 1972). The last method of NADPH
generation is by glucose shuttling into the PPS. It enters the PPS as glucose-6-phosphate
(G6P) and can then re-enter the glycolytic pathway as G6P after passing through the
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shunt (Salway, 1994). Prolactin inhibition causes levels of lipoprotein lipase, lipogenic
and glycolytic enzymes and enzymes involved in the PPS to fall significantly, indicating
that this hormone plays a regulatory role in lipid synthesis in the MEC (Rudolph et al.,
2011).

1.2.2.5.3 Protein synthesis
Protein synthesis occurring in the MEC must support both milk protein generation and
generation of proteins responsible for maintaining the cell and for producing and
transporting other milk components. Protein constitutes approximately 0.9%, 3.5%, and
12% of milk in humans, cattle, and mice, respectively (Jensen, 1995; Lonnerdal, 1985;
Gors et al., 2009; Boumahrou et al., 2009). Major milk proteins serve as carriers for
necessary vitamins and minerals, act as antimicrobials, anti-inflammatories, antioxidants
and specific immune protection, and serve as peptide and amino acid sources to the
growing offspring. Hormones and growth factors are also present in the milk, which are
thought to have possible roles in the neonate as well (Thompson et al., 2009). There are
two classifications of protein in milk: the caseins and the whey proteins. Caseins are
proteins that are insoluble in acidic pH range, while whey proteins are the proteins left in
the milk when caseins are removed by acidification. Caseins primarily exist in milk in the
form of micelles, which are structures formed with different major casein proteins
stabilized by kappa-casein and organic and inorganic ions, such as calcium (Jenness,
1974; Lonnerdal, 1985). Composition of these casein micelles and the whey protein
portion of milk vary among species. The only major casein in human milk is beta-casein,
which is almost entirely bound in micelles (Lonnderdal, 1985). The major casein in
30

	
  
bovine milk is αs1-casein, though it also contains a large amount of beta-casein and
smaller amounts of αs2- and gamma-casein. Fewer of the caseins in cow milk are bound
in micelles than in human milk (Jensen, 1995). Mouse milk contains large amounts of
both αs1- and beta- casein with smaller amounts of gamma-casein (Boumahrou et al.,
2009). All three contain smaller amounts of kappa-casein, which helps the others form
micelles in the milk. The whey portion of milk consists of different proportions of αlactalbumin, lactoferrin, beta-lactoglobulin, immunoglobulins, serum albumin, whey
acidic protein, enzymes, hormones and growth factors. Beta-lactoglobulin is primarily
found in cow milk, while whey acidic protein is primarily found in mouse milk.
Immunoglobulin and serum albumin are not made in the MEC, but transported from the
blood into the milk by these cells instead (Boumahrou et al., 2009; Kinsella and
Whitehead, 1989; Lonnderdal, 1985).
In addition to the secreted milk proteins, the cell is generating the proteins involved in
their production and the production of other milk components and cell maintenance
requirements. To support the high protein synthesis and processing demand, MEC
prepare for lactation by synthesizing more Golgi and rough endoplasmic reticulum
(Hollman, 1974), which can then aid in the production of the necessary proteins for milk
production. Among these proteins being produced are receptors for hormones and growth
factors secreted by other cells as well as components of cell signaling initiated by
activation of the receptors that cue the cell to produce the proteins needed for the jobs it
has to perform. Milk protein production as well as transport of immunoglobulin is largely
regulated by PRL and phosphorylation of PRLR’s downstream transcription factor,
STAT5. As previously mentioned, expression of enzymes involved in lactose synthesis
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and glycolytic and lipogenic pathways are also regulated by this hormone (Anderson et
al., 2007). Seen by the diverse roles of proteins in the MEC, the proper regulation of
protein synthesis is important for every aspect of milk production and secretion.
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1.2.2.6 Involution
After completion of functional development and the duration of lactation, the offspring
no longer require milk for nourishment and the gland undergoes involution, returning to a
near virgin state. This process has been most studied in mice and the following
information will stem from studies done in this species. Involution naturally occurs
gradually as offspring slowly shift to other food sources, though most studies investigate
the effects of abrupt weaning during mid-lactation in order to investigate the initiation of
different events occurring during involution (Richert et al., 2000). Consequently, timing
mentioned here is based off of abrupt weaning and involution while these events most
likely occur naturally in a similar manner but spread over the time of weaning.
Involution is a two-step process characterized by an early and reversible phase of MEC
apoptosis and shedding, followed by an irreversible stage of ECM and gland remodeling.
The initiation of involution is caused by milk stasis in the alveolar lumen and can be
reversed by suckling until remodeling has begun. In mice, the first stage of reversibility
lasts approximately 48 hours (Watson, 2006). When milk builds up in the lumen of the
alveoli, the MEC appear flattened due to the pressure of the building milk volume in the
extended alveoli (Richert et al., 2000) and this milk stasis induces expression of many
different factors implicated in the apoptotic pathways of involution. Milk accumulation
induces the expression of leukemia inhibitory factor (Lif), which appears in the alveolar
lumen and activates Lif-receptor (LifR) on the MEC luminal membrane. This
subsequently activates the Jak/STAT pathway, leading to the phosphorylation and
activation of STAT3. While STAT5 is important in development of the functional
mammary gland, STAT3 is essential in its involution after lactation (Watson et al., 2006;
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Stein et al., 2007). STAT3 induces expression of several important players in the onset of
involution such as C/EBPδ, IGFBP5 and regulatory subunits of PI3-kinase which are
involved in the anti-inflammatory pathway and inhibition of Akt activation, which would
otherwise aid in cell survival (Stein et al., 2007). Vitamin D receptor and the TNF/death
receptor pathway take a more direct approach. While they inhibit Akt, they also induce
caspase activity, which directly leads to apoptosis. At this stage of involution caspase
acitivty is only seen in cells shed into the lumen (Stein et al., 2007; Watson et al., 2006).
During the beginning phase of involution the only difference apparent in the gland is the
increased shedding of MEC, but the irreversible second stage is characterized by major
remodeling of the epithelium and stroma. Alveolar structures begin to collapse due to
detachment from the ECM and caspase activity is now seen in MEC still attached to the
luminal wall. Matrix metalloproteases (MMPs) are essential to this second stage of tissue
remodeling. They are responsible for the remodeling of the ECM and detachment from
the MEC layer. They also cleave plasminogen to plasmin, which is required for normal
stromal remodeling and adipocyte repopulation (Watson, 2006). When the alveoli
collapse, adipocytes begin accumulating lipid and filling in the open space of the stroma.
Infiltrating immune cells and surviving MEC perform clearance of dead cells and debris.
Resident MEC engulf milk fat globules, casein micelles, and apoptotic MEC and have the
ability to release the same key cytokines in response as the professional phagocytes. The
professional phagocytes also play a role in the clean up; macrophages and neutrophils
engulf milk components and phagocytize apoptotic cells (Atabai et al., 2007; Watson et
al., 2006). The rearranging and clearance continues until the gland has returned to a
mature, quiescent state that nearly mimics an adult virgin gland, which in mice is
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approximately 10-15 days post weaning (Richert et al, 2000; Lund et al., 1996; Lascelles
and Lee, 1978).
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1.2.2.7 Quiescence
After involution is complete, the mammary gland enters a period of quiescence until
pregnancy initiates another surge in growth and development. Although the postinvolution gland appears very similar to the mature virgin gland, there are persisting
differences. First, the morphological appearance of the gland varies slightly from the
virgin state. In humans and mice the complexity of the glandular tissue in the parous
gland is higher than in the nulliparous gland (Richert et al, 2000; Daniel and Silberstein,
1987). In addition to slight morphological differences, persisting molecular differences
exist. In a study by D’Cruz and colleagues (2002) the lasting effects of parity on
mammary gland gene expression was analyzed by microarray. Among the genes that
were down-regulated with parity were growth factors such as amphiregulin and IGF-1,
which promote cell growth and survival. Among the much longer list of up-regulated
genes were transcripts indicating a higher state of differentiation, such as all major milk
proteins, as well as immunoglobulin and factors involved in TGF-β signaling. These
differentially expressed transcripts indicate a higher order of differentiation as well as
more of a presence of immune cells and increased incidence of growth inhibition. If the
proteins of these transcripts are also expressed, this may help explain the welldocumented protection of parity from breast cancer (MacMahon et al., 1970; Britt et al.,
2007).
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1.2.3 Breast cancer incidence
Effect of parity on breast cancer risk has been recognized and documented since the early
1900s (Lane-Claypon, 1926; Wainwright, 1931). Both reduced and increased risks are
associated with different parity conditions. A transient increase in the risk of breast
cancer immediately following a pregnancy has been documented, which is also decreased
with increasing parity (Lambe et al., 1994). Risk of breast cancer development was found
to be reduced by 10% with each additional full term pregnancy (Lambe et al., 1996). Age
of first parity also has a large influence on risk. Women who are older than thirty at their
first full term pregnancy have a higher risk of developing breast cancer than nulliparous
women (Kelsey et al., 1993). While late age of first parity has a detrimental effect, early
age at first parity decreases risk of breast cancer development. The reduced risk of breast
cancer due to early age at first full term pregnancy became well known when MacMahon
and colleages performed a study in 7 different areas around the world and recognized and
stressed the importance of this factor (1970). Since then, studies in rodents and humans
have confirmed this protective factor of early pregnancy and have found that steroid
receptor positive breast cancer risk is decreased by early childbirth (Britt et al., 2007; Ma
et al., 2006). Several studies have focused on identification of the molecular factors
responsible for this phenomenon (D’Cruz et al., 2002; Ginger et al., 2001; Balogh et al.,
2006), and some potential molecules and processes have been discovered, but too few
reports and too many potential factors make concrete conclusions impossible. The studies
mentioned also all looked at persisting transcripts, while persisting protein expression
might provide a more focused list of potential future investigations. Continued
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comparisons between the different states of the gland offer increased potential of
unveiling persisting factors that might influence this difference seen in breast cancer risk.
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1.3 Bioinformatics
The expanding field of bioinformatics and the increasing importance for interdisciplinary
studies has been well documented and is only growing more apparent (Wolkenhauer and
Hofmeyr, 2013; NRC, 2010; Howe et al., 2008). Few experimentation techniques in
biological research remain that do not utilize computer software for some aspect of the
study and computers are necessary for storing, organizing and performing the analysis of
data. With the emergence of systems biology and “–omic” technologies, computer
analysis and data sharing has become fundamental to all progress. While individual fields
of study are becoming narrower in their focus and splitting into more divisions, these
divisions are becoming more difficult to assign under a larger category; that is, the lines
between fields of study are becoming blurred. It is becoming more important to have a
larger variety of knowledge in order to understand the details of these smaller topics. To
go along with these trends, individualized computer programming is being generated to
fit the needs of the specific fields of study. At the 2013 Plant and Animal Genome
conference in San Diego, an unofficial survey revealed that approximately 55 abstracts
were presented detailing computer programs designed to aid in -omic data management.
Among them, topics addressed included genome annotation, genotype and phenotype
association, transcriptome assessment, and regulation of gene expression. With the
narrowing focus of study topics and the growing amount of data that can be generated,
this observation did not come as a surprise.
Need for this cross-discipline has been recognized and attempts are being made to
advance its progress. Classes introducing undergraduates to bioinformatics tools have
appeared in many universities. Barbara May reported on the success of a class aimed at
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this goal. Students learned to analyze genomes and annotate genes, giving mostly positive
feedback (May, 2013). May is the far from the first to begin these types of studies; in
fact, it is now very common to even find degrees available involving bioinformatics in
universities. A survey was originally compiled in 2002 for a meeting of the American
Society of Information Science and Technology that included a list of universities that
offered bioinformatics related programs and degrees, and is continuously updated by
Bradley Hemminger at the School of Information and Library Services at the University
of North Carolina at Chapel Hill. In 2002 the list from the survey included 27 different
programs and by 2012 the list had increased to 87 different programs; that is 60 new
programs in ten years (SILS, 2013). The programs offer degrees related to bioinformatics
ranging from certificate programs and minors to BS, MS and PhD degrees. The degree
programs are based in departments ranging from biology to computer science to
mathematics departments. Some universities have their own department dedicated to
bioinformatics, and some are interdepartmental or interinstitutional programs.
Huge progress has been made in the recent years toward interdisciplinary studies, but
many of the programs are still new and continued advancement and improvement of
these programs is necessary for the advancement of the biological studies as the data sets
being produced are overwhelming without the help of advancing technology.
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1.4 Summary
Development of the mammary gland through the life of the female mammal is under the
influence of hormonal and intracellular signals, many of which are yet to be discovered.
These signals allow for the differentiation of the MECs into entities able to produce and
secrete the components of milk. In addition to the differentiation into milk producing
phenotypes, the cells also regress to a quiescent state during times of non-pregnancy.
Understanding of the events behind these developmental stages is of interest to several
different populations because of the potential influence on dairy production, breast
feeding, and breast cancer research.
Investigation into the development of the mammary gland is often performed by utilizing
large scale investigative methods such as microarray and proteomics. This type of
analysis can be made easier with the help of computer applications and collaboration with
technological fields. Specific computer software for a lab’s individual purposes can
relieve many of the difficulties that come with analyzing large data sets. Emerging
interdisciplinary study programs that allow students to learn the technological side and
biological side of this type of research will be of much value to future generations of
scientists.
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CHAPTER 2 – Proteomic Analysis of HC11 Differentiation
2.1 Introduction
The role of the differentiated mammary epithelial cell (MEC) during lactation is to
produce and transport all of the essential nutrients for the organism’s offspring including
lactose, fatty acids and triacylglycerol, amino acids and proteins, vitamins, minerals, and
several other important components needed for the growing infant (Mepham, 1983). The
nutrients available to the MEC, metabolic capabilities of the organism, and nutritional
needs of the young determine the components used and secreted in the milk. Because of
these determining factors some differences in molecular processing and the metabolic
pathways leading to the end products found in milk would be expected among species
and individuals, but despite the differences expected, the overall story should remain
similar due to the responsibility of the functional mammary gland across all mammals.
Mammary differentiation is studied through in vitro cell culture experiments, tissue
explants, and whole tissue samples (Desrivieres et al., 2003; Collier et al., 1977; D’Cruz
et al., 2002). Each method of study has advantages and disadvantages. Cell culture allows
for study of individual cell types, but removes the natural environment of the cells and
cell lines can misrepresent their primary cell counterparts. Explants and whole tissue
samples may provide more of a natural environment for the study of the gland, but
information is obtained for the gland as a whole, and information on individual cell types
is lost. A recent investigation in the Peterson lab was done using isolated primary MEC
from pregnant and lactating mice, which allows development in the natural environment
and the investigation of an individual cell type (Strand, 2012). Comparison of this data to
that of the HC11 cell line differentiated in culture would provide valuable information.
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This experiment analyzes the differing protein profiles between the undifferentiated and
differentiated states of the murine HC11 MEC line and compares this analysis with
different models of MEC differentiation. While the process of differentiation cannot be
fully understood with a just snapshot of the proteome on either side of the main event,
this analysis distinguishes aspects of MEC differentiation for which cell lines may or may
not be appropriate models and indicates the importance of comparative analysis among
species and models to reveal commonalities, which will be important for future attempts
at identifying central regulatory networks of MEC development.
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2.2 Methods
2.2.1 Cell culture
HC11 murine mammary epithelial cells (Ball et al., 1988) were grown to confluence in
RPMI 1640 media supplemented with 10% fetal bovine serum (FBS; Innovative
Research, Novi, MI), 1% penicillin/streptomycin (PS), 1% amphotericin B, 5 μg/ml
insulin, and 10 ng/ml epidermal growth factor (EGF). Half of the cells (n=3) were taken
for protein extraction at the point of confluence. Differentiation was then induced in the
remaining cells by incubating with EGF-free growth media for 48 hours followed by 4
days incubation in RPMI 1640 with 10% FBS, 1% PS, 1% amphotericin B, 5 μg/ml
insulin, 1μM dexamethasone, and 1μg/ml prolactin. The remaining cells (n=3) were used
for protein extraction after day 4 when domes were present in the cells, indicating a
differentiated state.
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2.2.2 Protein extraction
Three plates of cells were pooled for each protein extraction sample leading to 3 samples
per treatment (n=3). Media was aspirated from plates and cells were transferred to
microcentrifuge tubes and rinsed with PBS. Cells were then lysed by sonication in
homogenization buffer (7 M urea, 2 M thiourea, 40 mM tris base, 1% ASB-14, 40 mM
DTT, 0.5% ampholyte IPG, 0.001% bromophenol blue). Lysate was separated by
centrifugation for 30 minutes at 10,400 x g and 4°C and supernatant containing isolated
soluble proteins was transferred to a new tube.
Protein was precipitated with 10% trichloroacetic acid in acetone overnight at -20°C.
Protein was rinsed with 100% acetone and allowed to dry. Protein was solubilized
overnight at 4°C in rehydration buffer containing 7 M urea, 2 M thiourea, 2% CHAPS,
2% nonidet P-40, 100 mM DTE, 0.5% ampholyte IPG, and 0.002% bromophenol blue.
After centrifugation for 15 min at max speed and 4°C, supernatant containing solubilized
protein was transferred to a clean tube and stored at -80°C.
Protein was quantified using the 2-D Quant Kit (GE Healthcare Life Sciences, Pittsburgh,
PA).
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2.2.3 Two-dimensional gel electrophoresis (2DGE)
All equipment and materials used for 2DGE were purchased from Bio-Rad (Hercules,
CA) unless otherwise stated. All buffer reagents were purchased from Sigma-Aldrich (St.
Louis, MO) unless otherwise stated.
Immobilized pH gradient strips (11 cm, pH 3 -10) were actively rehydrated with the
rehydration buffer containing the protein samples for 12 hours at 50 V. Isoelectric
focusing (IEF) for the first dimension of separation was then performed at ~8,000 V and
20°C for 35,000 Volt hours. Active rehydration and IEF were performed using the
Protean IEF Cell. Strips were stored at -80°C until subjected to the second dimension.
For the second dimension, IPG strips containing protein were incubated with
equilibration buffer (375 mM tris-HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS,
0.002% bromophenol blue) containing 10 mg/ml DTT on a rotator for 15 min at room
temperature followed by incubation with equilibration buffer containing 25 mg/ml
iodoacetamide for 15 min. Proteins were then separated by molecular mass using 11 cm
10% polyacrylamide Criterion tris-HCl gels using the Criterion Dodeca Cell at 200 V,
allowing all gels to be run simultaneously. Samples were run in duplicate and proteins in
all gels were stained overnight with colloidal Coomassie Blue G-250 and de-stained with
Type I DI water.
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2.2.4 Gel analysis, spot picking and trypsin digestion
Stained gels were scanned using an Epson 1280 transparency scanner (Epson, Long
Beach, CA, USA). Scanned gel images were processed and analyzed by Delta 2D
(version 3.6, Decodon, Greifswald, Germany). Spots boundaries were defined and gels
were overlaid and fitted to align corresponding spots across gels. Differentially expressed
protein spots were identified using a t-test performed according to a null distribution that
was generated with 1000 permutations in order to account for unequal variance and nonnormal distribution of data.
Protein spots that differed in abundance due to treatment were excised using a manual 1.5
mm tissue puncher (Beecher Instruments, Prairie, WI) and stored at -80°C in 0.5 ml
microcentrifuge tubes until further processing. Gel plugs containing individual protein
spots were destained twice by incubation for 30 min at room temperature on a shaker
with destaining buffer (25 mM ammonium bicarbonate in 50% acetonitrile), dehydrated
with 100% acetonitrile, and digested overnight with trypsin solution (11 μg/μl MS-grade
porcine trypsin gold (Promega, Madison, WI) in 40mM ammonium bicarbonate/10%
acetonitrile) at 37°C. Digested proteins were eluted with analyte solution (0.1%
trifluoroacetic acid (TFA)/acetonitrile 2:1) for 30 min on a shaker at room temperature,
repeated twice. Samples were concentrated using a SpeedVac (Thermo Fisher Scientific,
Waltham, MA) at 45°C, resuspended in 6 μl of matrix solution (0.2 mg/ml α-cyano-4hydroxycinnamic acid in acetonitrile) and plated on an Anchorchip target plate (Bruker
Daltonics Inc., Billerica, MA). Plated protein spots were washed with 0.1% TFA and
recrystallized with acetone/ethanol/0.1% TFA (6:3:1).
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2.2.5 Mass spectrometry and protein identification
Peptide mass fingerprints (PMFs) were obtained using a matrix-assisted laser desorption
ionization tandem time-of-flight (MALDI TOF/TOF) mass spectrometer (Ultraflex II;
Bruker Daltonics Inc., Billerica, MA). Trypsin was used for internal mass calibration.
PMFs were analyzed using MASCOT server launched from BioTools software (Bruker
Daltonics, Billerica, MA) against the NCBI database. PMF were further analyzed using
MS/MS spectra using five to ten of the largest peaks per sample (excluding keratin and
trypsin). Spectra were internally calibrated and processed using FlexAnalysis software
(Bruker Daltonics, Billerica, MA). PMF and MS/MS spectra were combined and queried
as described for PMF spectra analysis using the MS/MS spectra.

48

	
  
2.3 Results
All gels containing both undifferentiated and differentiated HC11 cell protein extracts
were scanned and overlaid, creating one fused image for use in spot detection. Delta2D
analysis of the fused gel image detected a total of 337 individual protein spots (Figure 1).
Of the detected spots, 98 of these spots differed in abundance between the two treatments
(P < 0.02), and 90 of these differentially expressed spots were identified when using the
MASCOT server and matching the spectra to the NCBI Database (Table 1). Of the 90
identified spots, 41 were up regulated and 49 were down regulated in the differentiated
HC11 cells when compared to the undifferentiated cells.
Functional groups for the majority of the identified differentially expressed proteins
include energy metabolism (24 spots total; 18 up regulated/6 down regulated),
cytoskeletal dynamics (16 spots total; 6 up regulated/10 down regulated), transcriptional
regulation and RNA processing (11 spots total; 8 up regulated/3 down regulated), and
protein folding and processing (27 spots; 6 up regulated/21 down regulated).
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Figure 1. Fused gel image of HC11 protein spots. Protein was extracted from
undifferentiated and differentiated HC11 cells and protein was subjected to 2dimensional gel electrophoresis, stained with Coomassie blue, and analyzed by Delta 2D.
The image represents all gels fused into one image. Labeled spots were differentially
expressed between treatments (P < 0.02). Numbers correspond to “Spot ID” in Table 1.
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Figure 2. Heat map of differentially expressed
HC11 protein spots. Created by hierarchical
clustering using Pearson’s correlation of HC11
protein spots that were differentially expressed
between the undifferentiated and differentiated
states (P<0.02). Blue represents lower than
average
represents

protein

abundance,

higher

than

while

average

orange
protein

abundance for that particular spot. Rows
represent individual spots and the numbers
correspond to “Spot ID” in Table 1. Columns
represent

individual

gels.

treatment

gels

on

are

Differentiated
the

left

and

undifferentiated treatment gels are on the right.
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Figure 3. Proposed energy metabolism pathways in differentiated HC11 cells. Green
represents up regulation and red represents down regulation in differentiated cells (P <
0.02). The protein expression profile indicated shifts in pathway flux to spare glucose for
lactose synthesis, support energy generation from amino acids and redirect amino acid
carbon skeletons, oxaloacetate and acetyl CoA out of the mitochondria for use in
triacylglycerol synthesis in the cytosol.
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Table 1. List of identified protein spots that were differentially expressed between
undifferentiated and differentiated HC11 cells (P < 0.02). Under “Direction of
Regulation,” “up” indicates an increased abundance of the specified protein, while
“down” means the decreased abundance of the specified protein in the differentiated cells
relative to the undifferentiated cells. “Fold change” indicates magnitude of abundance
change and was calculated by dividing mean spot abundance of differentiated gels by
mean spot abundance of undifferentiated gels.
Spot
ID

Gene
Name

Protein Name

Direction
of
Regulation

Fold
change

angiogenesis & differentiation
40

angiopoietin-2

Angpt2

up

1.90

C1qbp

down

0.63

Gnb2l1
Ntrk1
Ywhag
Ywhaq

down
down
down
down

0.75
0.47
0.69
0.40

Actb
Gsn
Gsn
Itgb4
Krt14
Krt15
Krt17
Krt17
Krt5
Krt5
Krt5
Krt5
Krt7
Lmna
Lmna
Sept8

up
down
up
down
down
up
down
down
down
down
down
down
down
up
up
up

1.21
0.24
2.67
0.32
0.48
2.55
0.48
0.60
0.49
0.49
0.66
0.74
0.49
1.33
1.34
2.45

97
22
12
10

cell signaling
complement component 1 Q subcomponent-binding
protein, mitochondrial
guanine nucleotide-binding protein subunit beta-2-like 1
high affinity nerve growth factor receptor precursor
14-3-3 gamma protein
14-3-3 protein theta

68
54
2
9
63
66
65
67
70
37
71
77
59
75
76
60

beta-actin
gelsolin, cytosolic
gelsolin, cytosolic
integrin beta-4, partial
keratin, type I cytoskeletal 14
keratin, type I cytoskeletal 15
keratin, type I cytoskeletal 17
keratin, type I cytoskeletal 17
keratin, type II cytoskeletal 5
keratin, type II cytoskeletal 5
keratin, type II cytoskeletal 5
keratin, type II cytoskeletal 5
keratin, type II cytoskeletal 7
prelamin-A/C isoform A
prelamin-A/C isoform A
septin-8, partial

53
17
73

DNA replication & cell division
DNA replication licensing factor
Mcm7
proliferating cell nuclear antigen
Pcna
ruvB-like 1
Ruvbl1

down
down
down

0.64
0.14
0.48

55
88

ion transport
mitochondrial inner membrane protein, partial
voltage-dependent anion-selective channel protein 2

up
down

1.30
0.27

21

cytoskeleton

53
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Spot
ID

Gene
Name

Protein Name

Direction
of
Regulation

Fold
change

91
34

metabolism
long-chain specific acyl-CoA dehydrogenase,
mitochondrial precursor
medium-chain specific acyl-CoA dehydrogenase,
mitochondrial precursor
very-long-chain acyl-CoA dehydrogenase
aconitate hydratase, mitochondrial precursor
aldehyde dehydrogenase, mitochondrial precursor
arginase-1
arginase-1
ATP synthase subunit alpha, mitochondrial precursor
electron transfer flavoprotein subunit alpha, mitochondrial
glyceraldehyde-3-phosphate dehydrogenase
glyceraldehyde-3-phosphate dehydrogenase
3-hydroxyisobutyrate dehydrogenase, mitochondrial
precursor
malate dehydrogenase, cytosolic
3-mercaptopyruvate sulfurtransferase
C-1-tetrahydrofolate synthase, cytoplasmic
omega-amidase
succinyl-CoA:3-ketoacid coenzyme A transferase 1,
mitochondrial precursor
pyruvate carboxylase, mitochondrial isoform 1
phosphoglycerate kinase 1
pyruvate kinase M
phosphoserine aminotransferase isoform 1
succinate dehydrogenase flavoprotein subunit,
mitochondrial, partial
serine hydroxymethyltransferase 2, mitochondrial
transketolase

78

serum albumin precursor

Alb

up

1.61

61
36
7
41
27
79
19
46
49
45
47
3
23

protein synthesis & processing
t-complex protein 1 subunit beta
t-complex protein 1 subunit eta
cathepsin B
cathepsin D precursor
cathepsin D precursor
dnaJ homolog subfamily A member 1
elongation factor 1-delta
elongation factor 2
elongation factor 2
elongation factor 2
elongation factor 2
glycine - tRNA ligase
endoplasmin

Cct2
Cct7
Ctsb
Ctsd
Ctsd
Dnaja1
Eef1d
Eef2
Eef2
Eef2
Eef2
Gars
Hsp90b1

down
down
down
up
up
down
down
down
down
down
down
down
down

0.68
0.53
0.60
1.92
2.21
0.51
0.46
0.54
0.55
0.57
0.67
0.44
0.59

94
81
38
39
74
84
30
92
98
87
90
26
24
25
44
29
95
43
80
35
96
72

Acadl

up

1.53

Acadm

up

1.86

Acadvl
Aco2
Aldh2
Arg1
Arg1
Atp5a1
Etfa
Gapdh
Gapdh
Hibadh

up
up
up
up
up
down
up
up
up
up

1.70
1.45
2.19
2.10
2.17
0.42
2.41
1.28
1.66
2.05

Mdh1
Mpst
Mthfd1
Nit2
Oxct1

down
up
down
down
up

0.59
2.81
0.44
0.23
1.36

Pc
Pgk1
Pkm
Psat1
Sdha

up
up
down
down
up

1.84
1.33
0.79
0.57
1.77

Shmt2
Tkt

up
up

1.45
1.23

plasma protein
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Spot
ID
31
57
16
13
15
56
4
50
51
82
8
11
18
58
86
85
83
93
64
89
48
69
6
42
1

Protein Name
heat shock protein beta-1
chaperonin
nascent polypeptide-associated complex subunit alpha
isoform b
nucleophosmin isoform 1
nucleophosmin isoform 3
protein disulfide-isomerase
protein disulfide-isomerase A4 precursor
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
peptidyl-prolyl cis-trans isomerase D
proteasome subunit alpha type-2
proteasome subunit alpha type-5
40S ribosomal protein SA
t-complex polypeptide 1A

Gene
Name
Hspb1
Hspd1
Naca

Direction
of
Regulation
down
down
down

Npm1
Npm1
P4hb
Pdia4
Plod2
Plod2
Ppid
Psma2
Psma5
Rpsa
Tcp1

down
down
up
up
up
up
down
down
down
down
down

0.50
0.36
1.46
1.54
1.78
1.90
0.65
0.60
0.40
0.71
0.60

up

1.19

up

1.74

up
down
up
up
down
down
up
up
up

1.76
0.63
1.32
2.27
0.55
0.15
1.58
3.08
2.02

transcriptional regulation & processing
heterogeneous nuclear ribonucleoproteins A2/B1 isoform
Hnrnpa2b1
2
heterogeneous nuclear ribonucleoproteins A2/B1 isoform
Hnrnpa2b1
2
heterogeneous nuclear ribonucleoprotein A3 isoform c
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A/B isoform 2
Hnrnpab
heterogeneous nuclear ribonucleoprotein H2
Hnrnph2
max-like protein X isoform gamma
Mlx
tRNA (cytosine(34)-C(5))-methyltransferase
Nsun2
ribonuclease/angiogenesis inhibitor
Rnh1
TAR DNA-binding protein 43 isoform 1
Tardbp
TAR DNA-binding protein 43 isoform 1
Tardbp
tripartite motif protein 28
Trim28

55

Fold
change
0.16
0.42
0.37

	
  
2.4 Discussion
In this study, protein expression of the HC11 murine MEC line was compared between
its undifferentiated state, used to represent the theoretical state of pregnancy, and its
differentiated state, used to represent the theoretical state of lactation. Samples were
taken at the proliferating stage and after being treated with a three-hormone cocktail
(dexamethasone, insulin, prolactin; DIP), respectively. Treatment with DIP has been
shown to yield cells with characteristics of a lactating MEC based on expression of betacasein and formation of mammospheres (Ball et al., 1988; Blachford et al., 1995;
Morrison and Cutler, 2009). The method of analysis used in 2DGE allows the discovery
of many protein changes occurring at a point in time before and after differentiation, but
it does not provide a complete list of all occurrences leading to the differentiated cell
type. This analysis allows the proposal of potential events occurring, which can then be
explored and validated through additional experimentation.
Changes in the protein profile of these HC11 cells after differentiation are largely in
agreement with a very similar study performed ten years prior (Desrivieres et al., 2003)
and appear to indicate shifts appropriate for the switch to a milk producing phenotype.
Differential expression of identified proteins involved in energy metabolism indicated
shifts in pathway flux to spare glucose for lactose synthesis, support energy generation
from amino acids, and redirect amino acid carbon skeletons, oxaloacetate and acetyl CoA
out of the mitochondria for use in triacylglycerol synthesis in the cytosol. Shifts in
cytoskeletal proteins indicated a change to a polarized and stable phenotype and to
support vesicular transport and transcriptional activity of the cell. Increased abundance of
many transcriptional regulators and RNA processing proteins suggested an increased
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output of transcripts, while the majority of changes involving protein processing implied
the opposite – decreased protein biosynthesis and processing.

2.4.1 Metabolism
Changes in abundance of energy metabolism enzymes and proposed metabolic pathways
in use in the differentiated state of the HC11 cells are shown in Figure 3 and should be
referenced as the discussion proceeds. All differentially expressed proteins mentioned are
also listed in Table 1 of the results section.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and phosphoglycerate kinase
(PGK1) are both increased in differentiated cells, appearing to support the possible
increase in the process of glycolysis as their reactions reversibly convert glyceraldehyde
3-phosphate

to

1,3-bisphosphoglycerate,

and

1,3-bisphosphoglycerate

to

3-

phosphoglycerate, respectively. The increase of pyruvate kinase (PKM) seen previously
in multiple studies would substantiate the idea of increased glycolysis leading to high
levels of pyruvate to be used for ATP production, all driven by a high glucose supply
(Desrivieres et al., 2003; Rudolph et al., 2007; Strand, 2012). In this particular study,
however, PKM was actually decreased in differentiated cells, leading to an alternative
explanation of glucose sparing and energy production through other means. Down
regulation of PKM would lead to a buildup of its substrate, phosphoenolpyruvate (PEP),
as well as a decreased production of pyruvate from PEP. Phosphoglycerate kinase and
GAPDH were both increased in the differentiated cells, but these enzymes can catalyze
the conversion of their substrates and products reversibly. The accumulation of PEP,
down regulation of PKM and increase of PGK1 and GAPDH would drive the direction of
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glycolytic enzyme activity to move toward the product glyceraldehyde 3-phosphate
(G3P).

This pool of G3P could then serve several purposes. Some G3P could be

converted to dihydroxyacetone phosphate (DHAP) and be used for triacylglycerol
(TAG) synthesis. A portion of G3P could also be converted to glucose 6-phosphate
(G6P) and shuttled into the pentose phosphate shunt (PPS) in order to produce the
NADPH needed for fatty acid synthesis – a possibility supported by the up regulation of
the PPS enzyme transketolase (TKT) in the differentiated state. This conversion to G6P
would also allow more of the glucose in the cell to be directed toward lactose synthesis,
which is in agreement with the previous findings that glucose phosphate isomerase has
been shown to decrease in transcript abundance at onset of lactation, which would
decrease the entrance of G6P into glycolysis (Rudolph et al., 2007).
If the enzyme abundance indicates the use of glucose for lactose synthesis and reverse
glycolytic substrate conversion so as to shuttle substrates away from entering the TCA
cycle, it is important to consider source of energy production and level of energy
utilization in the MEC. Though the enzymes mentioned above have changed in
abundance from the pregnant to the lactating state of the MEC, they are not nonexistent
in one state or the other. A small amount of glucose is still being used for energy and a
portion is still being transported into the PPS. Also, the energy production seems to be
reduced from the proliferative pregnant state of the cell, which very well may require a
higher level of ATP output relative to the differentiated lactating-like state. This idea is
supported by the decrease in ATP synthase subunit alpha (ATP5A1), which is part of the
F1, catalytic portion of the ATP synthase enzyme and required for the production of ATP
in the respiratory chain (Wang and Oster, 1998).
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In addition to requiring less energy in total, the differentiated cell appears to use more
amino acids for energy and nutrient production. Serine hydroxymethyltransferase 2
(SHMT2) is increased in abundance and catalyzes the production of serine from glycine
in the mitochondria, which can then be converted to 2-phosphoglycerate and transported
into the cytosol where it can enter the glycolytic pathway to be used for production of
energy or milk components. While production of pyruvate through means of glycolysis
may be decreased due to down regulated PKM, it can also be made from threonine in a
series of three conversions of which the last is catalyzed by aldehyde dehydrogenase
(ALDH2); ALDH2 is increased in differentiated HC11 cells. Several acyl CoA
dehydrogenases (ACAD) were also up regulated. These enzymes could be a part of fatty
acid remodeling, or could serve to produce acetyl CoA from lysine in the mitochondria.
Lysine is converted to α-ketoadipate in the cytosol and transported into the mitochondria,
changed into glutaryl CoA and acted upon by ACAD, eventually leading to the
production of acetyl CoA (Salway, 1994). This provides a pool of acetyl CoA in the
mitochondria that is produced from a source other than pyruvate. Arginase (ARG1)
abundance has repeatedly been shown to increase in the lactating mammary gland,
including in this experiment (Yip and Knox, 1972; Oka and Perry, 1974; Mezl and Knox,
1977). The absence of other enzymes involved in the urea cycle has indicated an alternate
role in the production of proline and glutamate from arginine. Other enzymes in these
pathways have also been shown to increase in the lactating mammary gland and are
thought to be necessary for production of milk proteins (Yip and Knox, 1972; Mezl and
Knox, 1977).
Complementing the increased use of amino acids for energy and decreased overall need
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for ATP, increased abundance of pyruvate carboxylase (PC), which converts pyruvate
into oxaloacetate, and of aconitase (ACO2), which catalyzes the bidirectional conversion
of citrate and isocitrate, supports increased production of citrate from oxaloacetate and
acetyl CoA. In the rodent mammary gland, the citrate can be shuttled out of the
mitochondria and the enzyme citrate lyase would catalyze the splitting of citrate back into
oxaloacetate and acetyl CoA in the cytosol. This shuttling of citrate out of the
mitochondria to allow acetyl CoA escape from the mitochondria for use in fatty acid
synthesis has been documented, but is usually in concert with conversion of oxaloacetate
into malate by cytosolic malate dehydrogenase (MDH1), and then into pyruvate for
reentrance into the TCA cycle as part of the pyruvate/malate cycle, which is a means of
NADPH production (Anderson et al., 2007; Rudolph et al., 2007). In this study MDH1
was down regulated, so the excess oxaloacetate produced must be directed in an
additional, or different direction. Instead, the oxaloacetate could be converted into PEP
by PEPCK in the cytosol and contribute to the reverse activity of glycolytic enzymes and
continued increase of TAG synthesis, the PPS, and glucose sparing for lactose
production.
Energy metabolism changes found in the transformation of HC11 cells from the
undifferentiated to differentiated state largely support current knowledge of rodent
mammary metabolism with just two enzyme regulation changes that seem to differ from
previous findings, but may bring into question aspects of metabolic pathway flux. The
decreased abundance of PKM and MDH1 in the differentiated state has not previously
been detected and indicates a redirection of substrates in the glycolytic pathway and use
of alternate materials for pyruvate production. This discovery may be due to differing
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nutrient availability or differences in this HC11 cell line with other models and warrants
further investigation.

2.4.2 Cytoskeleton
Changes in the profile of cytoskeletal proteins suggested increased stability of the cell
and active vesicular trafficking as well as decreased need for filaments required for cell
motility. Most of the keratins found, which included 5, 7, 14 and 17, were down regulated
while the only up regulated keratin was 15. This was an interesting find that seems to be
in agreement with some literature because keratin 15 (KRT15) has been found down
regulated in proliferating cells and up regulated in differentiated, stable cells, while others
such as keratins 5 and 14 specifically are associated with mitotically active cells and are
down regulated in differentiated and phenotypically stable cell types (Porter et al., 2000;
Waseem et al., 1999). Interestingly, although this has been found in certain studies in
keratinocytes, a study on human mammary gland proposes KRT15 as a marker for a
luminal progenitor cells and found it to be absent in differentiated lactating cells but
present in undifferentiated cells (Moriera et al., 2010). This is an important difference to
investigate and may be based on difference in species or cell source.
Prelamin-A (LMNA) was up regulated in the differentiated mammary epithelial cell. This
protein can be in several forms as a precursor to mature lamin A and this precursor has
been found to be responsible for several roles such as localization of other proteins to the
nucleus and regulation of transcription due to transcription factor sequestration. It has
been found to interact in this way with SREBP1, which is known to play a role in
regulating lipid metabolism (Lattanzi, 2011).
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Integrin beta-4 (ITGB4) serves with integrin alpha-6 as a receptor for laminins on the
basement membrane and is thought to exist primarily on basal cells and to not be present
on most luminal cells (Yang et al., 2009). In this study ITGB4 was down regulated in
differentiated HC11 cells, which is interesting because the line arose from a luminal
mammary epithelial cell and is seen in this study not only to express it, but also to change
its expression with hormone treatment directing a differentiation-like process.
Gelsolin (GSN) was found to be both up and down regulated, meaning the predominating
post-translational modified form of GSN was changed. Gelsolin is primarily known for
its actin regulatory actions due to its ability to both sever and cap actin filaments to aid in
cell mobility, but it also has a role in the progression of apoptosis. It has been shown to
inhibit the release of cytochrome c from mitochondria, disallowing caspase-3 activation
and inhibiting early stages of apoptotic signaling, therefore stabilizing the cell (Koya et
al., 2000). Perhaps the up regulation of this form of GSN is occurring and allowing the
differentiated cell to remain stable until involution. If the up regulated form of GSN is
due to actin remodeling roles, perhaps the rearrangement of actin filaments is necessary
to allow for vesicular trafficking and transport of milk components out of the cell. This is
supported by the congruent up regulation of beta-actin and septin 8 in the differentiated
HC11 cells. Septin 8 has been associated with vesicular trafficking and exocytosis in
neural cells and is involved in secretory processes in the prostate, testis and ovary (Blaser
et al., 2003; Ito et al., 2009; Shiryaev et al., 2012); septin 8 is possibly playing the same
role in the mammary epithelial cell, aiding in transport and exocytosis of milk
components.
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2.4.3 Protein biosynthesis and processing
Of the twenty-two differentially expressed proteins involved in the biosynthesis and posttranslational processing of protein, only four were up regulated in the differentiated cells.
The majority of proteins was down regulated and involved the management of tRNAs,
ribosome synthesis, and chaperoning other proteins. Of the four up regulated proteins,
two of them were protein disulfide-isomerases (P4HB and PDIA4), which help rearrange
disulfide bonds. This finding is interesting because the major whey protein in mouse milk
is whey acidic protein (WAP). This protein is cysteine-rich and contains two separate
domains, joined by disulfide bonds (Hennighausen and Sippel, 1982; Neville and Daniel,
1987). This increase could indicate a shift in protein product priority. The others were
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) and cathepsin D (CTSD)
which form sites for carbohydrate attachment for collagen crosslink stability and break
down proteins, respectively (Mercer et al., 2003; Benes et al., 2008). This mass down
regulation of protein processing capability may be due to either a decreased overall
amount of protein being produced in the differentiated state relative to the
undifferentiated state, or a large, but more directed production of fewer specific proteins
to be used in the production and secretion of milk components.

2.4.4 Transcriptional regulation and RNA processing
Transcript production and processing appeared to be increased immensely. There were a
total of 9 proteins found to change in abundance; 3 proteins were down regulated and 6
proteins were up regulated. The up regulated proteins were mostly involved in processes
indicative of a higher number of transcripts being present in the cell. Four different
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proteins in the heterogeneous nuclear ribonucleoprotein (HNRNP) family were found to
differ in abundance; A3, A2B1 and H2 were up regulated and AB was down regulated.
HNRNPA2B1 and HNRNPH2 are involved in pre-mRNA processing (Dreyfuss et al.,
2002; He and Smith, 2009) and A3 is involved in the cytoplasmic trafficking of RNA and
mRNA maturation (Ma et al., 2002; Papadopoulou et al., 2012). The down regulated
HNRNPAB acts as a repressor of transcription (Kamada and Miwa, 1992). TAR DNAbinding protein 43 (TARDBP) is up regulated and has been shown to interact with
several hnRNP members and to assist in mRNA processing and stability (Buratte and
Buralle, 2008). Max-like protein X (MLX) was also increased in abundance and is known
to interact with another protein, MondoA. This heterodimer has been implicated in the
transcriptional regulation of many metabolic genes, specifically glycolytic enzymes (Sans
et al., 2006).

2.4.5 Comparison to Previous Studies
The changes in functional groups in HC11 seen in this study were largely in agreement
with a much earlier study performed in the same cell line. Desrivieres and colleagues
made the same comparison in 2003 using the HC11 cell line and even given the methods
and time difference, a similar story was told. Protein folding and stability proteins were
mostly down regulated while RNA processing and metabolic proteins were both largely
up regulated in the differentiated HC11 cells. Cytoskeletal proteins were split in their
regulation with many keratins being down regulated. There were many proteins identified
in each experiment that were not identified in the other, but the general picture that each
tells appears to agree and the majority of the proteins that were identified in both studies
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shared direction of regulation. The level of similarity allowed confidence in the
repeatability of 2DGE experiments and the integrity of the line, but there were a couple
differences worth mentioning. The first small difference was that PDI was down
regulated in Desrivieres’ differentiated HC11 cells whereas it was up regulated in the
present study. This does not have many clear implications, but was a specific difference
in the two studies. In the Desrivieres study, PKM was up regulated in differentiated cells
whereas it was down regulated in the present HC11 study. As previously mentioned, this
is an interesting difference because its level of abundance potentially changes the flow of
substrates through glycolysis and the direction of energy metabolism. This difference in
regulation between these two studies of HC11 differentiation indicates that this regulation
change does not likely reflect the cell source and most likely differs due to environment.
Proteome changes in HC11 MEC were very different in all major functional categories
from those observed during differentiation in the MAC-T bovine MEC line (Strand,
2012). MAC-T showed opposite regulation of several specific protein processing and
cytoskeletal proteins. Very few proteins involving RNA processing were even identified
in the MAC-T cells so a proper comparison could not be made. Metabolic proteins
differed quite a bit, but seemed to accurately demonstrate differences in the metabolic
enzyme profiles of bovine and murine species. MAC-T cells indicated forward glycolytic
enzyme activity, build-up of isocitrate and increased PPS activity. Data from a primary
bovine comparison would be an important contribution to the comparison in order to
accurately distinguish cell line and specie nuances.
HC11 cells and primary MEC isolated from pregnant and lactating mice (Strand, 2012)
exhibited similar changes in proteins involved in metabolism and protein synthesis and
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folding, but opposite regulation of RNA processing and cytoskeletal proteins. Both the
primary cells and cell line displayed increases in glycolytic enzymes and citrate
production due to up regulation of ACO2. Though not identified in the cell line, citrate
lyase was found to be up regulated in the primary cells, supporting the idea of citrate
shuttling out of the mitochondria and splitting into oxaloacetate and acetyl CoA for use in
fatty acid and TAG synthesis, as previously proposed.
Interestingly, TKT was down regulated in the primary cells vs. the up regulation of TKT
in the cell line, perhaps because the primary cells were obtaining some fatty acids from
the adipocytes and the FA production rate was not as high as in the cell line, requiring
less NADPH. Pyruvate dehydrogenase was up regulated and PKM was not identified in
the primary cells, suggesting a possible flow of substrates down the glycolytic pathway
and into the mitochondria and TCA cycle. Respiratory chain energy production also
seemed to be increased due to the increase in ATP5A1 in primary lactating cells. Though
the regulation of many enzymes involved in energy metabolism are left unknown through
proteomics and absence of their finding does not mean they did not change, speculations
can be made based on findings that did occur. Regulation of enzymes found in the
primary cells seem to suggest a possible increased use of glucose for glycolysis and
energy production relative to the cell line. This possible difference in metabolism could
be explained in several ways. Signals from adjacent cells or even hormone signals that
were present in the mammary gland of the mice before MEC isolation could have
influenced regulation of different metabolic enzymes in the primary cells. The primary
cells could have also been provided higher levels glucose prior to isolation through diet,
glycogenolysis and/or gluconeogenesis in the liver of the mouse and this excess glucose
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was then available for use in lactose synthesis, energy production, and other milk
component production.
Speculation about the difference in the cytoskeletal regulation and transcriptional
regulation is more difficult. More specific cytoskeletal component comparisons would be
useful as there were only two shared between the two models, LMNA and KRT5, and
these were oppositely regulated. The environment in which each model was maintained
was very different and surely influences the cytoskeletal components needed to maintain
adhesion and structure of the cells, suggesting explanation for differences occurring. The
RNA processing proteins were oppositely regulated which could also be a consequence
of their environments. Perhaps the cell line has increased production of more transcripts
due to the lack of negative regulation from surrounding cell types, or they may actually
require the extra transcripts due to the lack of paracrine factors or other needs due to
environment.
This comparison shows that HC11 cells, which are currently widely used to investigate
events occurring in the MEC, may need to be analyzed more closely before trusting
accuracy of findings. This study showed a striking difference in RNA processing and
cytoskeletal dynamics between this cell line and primary MEC and some subtle yet
meaningful differences in energy metabolism, which is reason to question the accuracy of
the HC11 cell line to use as a model for certain aspects of MEC differentiation.
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CHAPTER 3 – Proteomic analysis of isolated primary virgin, pregnant and primiparous
quiescent mammary epithelial cells
3.1 Introduction
Investigation of the molecular events occurring throughout mammary development is an
important and heavily studied topic because of its potential influence on the dairy
industry, breast feeding, and the fight against breast cancer. Technologies aimed at
obtaining large and undefined data sets such as microarrays and 2DGE have been used to
analyze the changes occurring in the gland, which provide the ability to discover new
molecules and processes involved that were previously not connected to mammary
development. Most of these studies perform analysis on RNA or protein extracts obtained
from whole tissue, which includes all information from not only the parenchyma but also
the adipose, immune cells, endothelium and extracellular matrix (Rudolph et al., 2003;
D’cruz et al., 2002; Beddek et al., 2003). This approach provides insight into changes in
the entire gland, but does not give a clear picture of events occurring in the mammary
epithelial cells and requirements for their differentiation into lactating cells. Other –omic
investigations have analyzed changes during the differentiation of cell lines, such as the
murine HC11 and the bovine MAC-T lines (Desrivieres et al., 2003; Strand, 2012). Data
provided by these studies is more representative of the MEC itself, but there are also
limitations of analyzing cell lines and in vitro experimental data. Cell lines have potential
of changing over time and expressing transcripts and proteins unrepresentative of primary
MEC and any data obtained in vitro is generated lacking influence from surrounding
tissues and the natural environment for the MEC. Analysis of primary MEC from
different stages of mammary development would eliminate the limitations of in vitro and
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whole gland investigations by being representative of the MEC and receiving cues from
their true environment throughout development.
Previous investigation into changes occurring between pregnant and lactating states of
the primary murine MEC has been performed in the Peterson lab (Strand, 2012). Results
of this previous investigation were compared with the in vitro induction of a
differentiated-like state of the HC11 murine MEC line by hormone treatment to elucidate
similarities and differences between these two models of MEC differentiation; this
comparison was discussed in the previous chapter. Changes in the mammary gland and
MEC occur between all stages of development including from the virgin state to the
pregnant state and from the lactating state back to quiescence. The following
investigation aims to add to the data set from primary isolated MEC in different stages of
mammary development. Primary MEC from the virgin state are isolated and compared to
MEC from the pregnant state and primiparous quiescent state of the gland. The discovery
of protein changes will add to the knowledge of the events that occur in preparation for
the shift to a lactating phenotype and unveil changes in protein expression that persist in
the MEC after full development, function, and involution of the mammary gland.

69

	
  
3.2 Methods
3.2.1 Animals and breeding
All procedures were approved by the Cal Poly Institutional Animal Care and Use
Committee. ICR mice (Taconic, Hudson, NY) were housed with a 12 h light schedule
and ad libitum access to food and water. Samples were taken from virgin and pregnant
mice between 10 and 11 weeks of age. Pregnant samples were taken at day 10 of
pregnancy. Due to resource and scheduling constraints, primiparous samples were taken
from mice approximately 23 weeks in age. Primiparous mice were weaned at 21 days of
lactation and samples were taken at 18 days post-weaning. Estrous cycle was not taken
into account for virgin or primiparous samples. All mice were euthanized by CO2
asphyxiation followed by cervical dislocation. Mammary tissue was harvested from all
glands. Samples consisted of all glands pooled from one mouse. Three samples for each
stage of development were used.
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3.2.2 Primary mammary epithelial cell isolation
Immediately following euthanasia all mammary tissue was removed and rinsed in 1X
Hank’s Balanced Salt Solution. Tissue was then transferred and minced in digestion
media containing collagenase, trypsin and EDTA in Dulbecco’s Modified Eagle Medium.
Media containing tissue was placed in an incubated shaker set at 37°C for 90 minutes,
with disruption by pipet every 30 minutes. Cells were pelleted and red blood cells were
removed by incubation with blood cell lysis buffer (8.3 g/L ammonium chloride in 0.01M
Tris-HCl). The remaining pellet was then plated in T-75 flasks for one hour in order to
remove the rapidly adherent fibroblasts. The cell suspension was then incubated with
EDTA and DNase solutions before being filtered through a 100um filter. Epithelial cells
were re-suspended in DMSO cell freezing media, brought down to -80°C and stored in a
liquid nitrogen tank until extraction.
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3.2.3 Protein extraction
Protein extractions were performed the same as was specified in section 2.2.2.

3.2.4 Two-dimensional gel electrophoresis (2DGE)
Two-dimensional gel electrophoresis was performed the same was as specified in section
2.2.3.

3.2.5 Gel analysis, spot picking and trypsin digestion
Gel analysis, spot picking and trypsin digestion were performed the same as specified in
section 2.2.4.

3.2.6 Mass spectrometry and protein identification
Mass spectrometry and protein identification were performed the same as specified in
section 2.2.5.
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3.3 Results
All gels containing virgin, pregnant, and primiparous quiescent primary cell protein
extracts were scanned and overlaid, creating one fused image for use in spot detection.
Delta2D analysis of the fused gel image detected a total of 234 individual protein spots
(Figure 4). Comparisons were then made between the virgin and pregnant gels and
between the virgin and primiparous quiescent gels. Of the detected spots, 67 and 73 of
these spots differed in abundance between the virgin and pregnant sample comparison
and the virgin and quiescent sample comparison, respectively (P < 0.02). Of these
differentially expressed spots, 31 and 36 were identified for the virgin and pregnant
comparison (Table 2) and the virgin and quiescent comparison (Table 3), respectively
when using the MASCOT server and matching the spectra to the NCBI Database. Of the
31 identified proteins in the virgin and pregnant comparison, 3 were up and 28 were
down regulated in the pregnant MEC relative to the virgin MEC. Of the 36 identified
proteins in the virgin and pregnant comparison, 5 were up regulated and 31 were down
regulated in the primiparous quiescent MEC relative to the virgin MEC.
Functional groups for the majority of the identified differentially expressed proteins in
the virgin and pregnant MEC comparison include energy metabolism (11 spots total; 1 up
regulated/10 down regulated), cytoskeletal dynamics (7 spots total; 1 up regulated/6
down regulated), and protein synthesis and processing (6 spots total; 1 up regulated/5
down regulated).
Functional groups for the majority of the identified differentially expressed proteins in
the virgin and primiparous quiescent MEC comparison include energy metabolism (9
spots total; 1 up regulated/ 8 down regulated), cytoskeletal dynamics (7 spots total; 3 up
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regulated/4 down regulated), protein synthesis and processing (9 spots total; 1 up
regulated/8 down regulated), and transcriptional regulation and RNA processing (3 spots
total; all down regulated).
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Figure 4. Fused gel image of isolated primary mammary epithelial cell protein spots.
Protein was extracted from isolated primary virgin, pregnant, and primiparous quiescent
mouse mammary epithelial cells. Proteins were subjected to 2-dimensional gel
electrophoresis, stained with Coomassie blue, and analyzed by Delta 2D. The image
represents all gels fused into one image. Labeled spots were differentially expressed
between treatments (P < 0.02). Numbers correspond to “Spot ID” in Table 2 and Table 3.

75

	
  
Figure 5. Heat map of protein spots that were
differentially expressed between isolated primary
MEC from virgin and pregnant mice. Created by
hierarchical clustering using Pearson’s correlation of
HC11 protein spots that were differentially expressed
between the undifferentiated and differentiated states
(P < 0.02). Blue represents lower than average
protein abundance, while orange represents higher
than average protein abundance for that particular
spot. Rows represent individual spots and the
numbers correspond to “Spot ID” in Table 2.
Columns represent individual gels. Virgin treatment
gels are on the left and pregnant treatment gels are on
the right.
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Figure 6. Heat map of protein spots that were
differentially expressed between isolated primary MEC
from virgin and primiparous quiescent mice. Created by
hierarchical clustering using Pearson’s correlation of
HC11 protein spots that were differentially expressed
between the undifferentiated and differentiated states (P
< 0.02). Blue represents lower than average protein
abundance, while orange represents higher than average
protein abundance for that particular spot. Rows
represent individual spots and the numbers correspond
to “Spot ID” in Table 3. Columns represent individual
gels. Virgin treatment gels are on the left and
primiparous quiescent treatment gels are on the right.
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Table 2.

List of identified protein spots that were differentially expressed between

isolated primary virgin and pregnant MECs (P < 0.02). Under “Direction of Regulation,”
“up” indicates an increased abundance of the specified protein, while “down” means the
decreased abundance of the specified protein in the pregnant cells relative to the virgin
cells. “Fold change” indicates magnitude of abundance change and was calculated by
dividing mean spot abundance of pregnant gels by mean spot abundance of virgin gels.
Spot
ID

Gene
Name

Protein Name

Direction
of
Regulation

Fold
change

cytoskeleton
95

keratin, type II cytoskeletal 1

Krt1

down

0.35

151

keratin, type I cytoskeletal 16

Krt16

down

0.59

194

keratin, type I cytoskeletal 19

Krt19

up

1.39

19

LIM and SH3 domain protein 1

Lasp1

down

0.63

93

prelamin-A/C isoform A precursor

Lmna

down

0.49

lamin-B1

Lmnb1

down

0.69

PDZ and LIM domain protein 1

Pdlim1

down

0.56

105
20

immune function
230

catalase

Cat

down

0.47

202

immunoglobulin heavy chain variable region

Ighvdj

down

0.73

Vdac2

down

0.64

Acadl

up

1.65

ion transport
2

193

voltage-dependent anion channel 2
metabolism
long-chain specific acyl-CoA dehydrogenase,
mitochondrial precursor

15

short-chain specific acyl-CoA dehydrogenase

Acads

down

0.75

40

acetyl-CoA acetyltransferase, mitochondrial precursor

Acat1

down

0.71

228

aconitate hydratase, mitochondrial precursor

Aco2

down

0.56

234

aconitate hydratase, mitochondrial precursor

Aco2

down

0.66

Aldoa

down

0.68

28

fructose-bisphosphate aldolase A isoform 1 precursor
electron transfer flavoprotein subunit alpha,
mitochondrial

Etfa

down

0.46

41

glyceraldehyde-3-phosphate dehydrogenase

Gapdh

down

0.64

50

malate dehydrogenase

Mdh2

down

0.55

transketolase

Tkt

down

0.79

heat shock protein 75 kDa, mitochondrial

Trap1

down

0.56

43

224
92

plasma protein
103

alpha-fetoprotein, partial

Afp

down

0.58

100

serum albumin

Alb

down

0.53
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Spot
ID
160
72

Gene
Name

Protein Name

Direction
of
Regulation

Fold
change

serum albumin

Alb

down

0.52

serotransferrin precursor

Tf

down

0.46

protein synthesis & processing
102

heat shock protein 1A

Hspa1a

down

0.40

heat shock protein 70 cognate

Hspa8

up

3.74

117

alpha-1-antiproteinase precursor

SERPINA1

down

0.53

122

alpha-1-antiproteinase precursor

SERPINA1

down

0.50

135

alpha-1-antiproteinase precursor

SERPINA1

down

0.41

190

elongation factor Tu, mitochondrial isoform 2

Tufm

down

0.72

82
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Table 3.

List of identified protein spots that were differentially expressed between

isolated primary virgin and primiparous quiescent MECs (P < 0.02). Under “Direction of
Regulation,” “up” indicates an increased abundance of the specified protein, while
“down” means the decreased abundance of the specified protein in the primiparous cells
relative to the virgin cells. “Fold change” indicates magnitude of abundance change and
was calculated by dividing mean spot abundance of primiparous quiescent gels by mean
spot abundance of virgin gels.
Spot
ID

Gene
Name

Protein Name

Direction
of
Regulation

Fold
change

cytoskeleton
189
192
95
151
194
93
20

Actb
Actb
Krt1
Krt16
Krt19
Lmna
Pdlim1

up
up
down
down
up
down
down

1.47
2.34
0.59
0.51
1.87
0.43
0.55

DNA replication & cell division
cell division control protein 42 homolog
CDC42

down

0.36

immune function
immunoglobulin heavy chain variable region

Ighvdj

down

0.60

voltage-dependent anion channel 2

Vdac2

down

0.68

15
234
170
175
146
28
38
106
224

metabolism
short-chain specific acyl-CoA dehydrogenase
aconitate hydratase, mitochondrial precursor
aldehyde dehydrogenase, mitochondrial precursor
ATP synthase subunit beta, mitochondrial precursor
dihydrolipoamide dehydrogenase precursor
electron transfer flavoprotein subunit alpha, mitochondrial
fumarate hydratase, mitochondrial precursor
succinate dehydrogenase flavoprotein subunit
transketolase

Acads
Aco2
Aldh2
Atp5b
DLD
Etfa
Fh
Sdha
Tkt

down
down
down
down
down
up
down
down
down

0.63
0.61
0.48
0.55
0.46
1.12
0.81
0.34
0.66

103
160
72
75
84

alpha-fetoprotein, partial
serum albumin
serotransferrin precursor
serotransferrin precursor
serotransferrin

Afp
Alb
Tf
Tf
Tf

down
down
down
down
down

0.60
0.60
0.47
0.50
0.44

186
66

elongation factor 1-gamma
heat-shock protein 84

Eef1g
Hsp90ab1

down
down

0.42
0.48

25
202

actin, cytoplasmic 1
actin, cytoplasmic 1
keratin, type II cytoskeletal 1
keratin, type I cytoskeletal 16
keratin, type I cytoskeletal 19
prelamin-A/C isoform A precursor
PDZ and LIM domain protein 1

ion transport
2

plasma protein

protein synthesis & processing
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Spot
ID
219
82
136
122
135
119
190
45
177
69

Protein Name
endoplasmin
heat shock protein 70 cognate
60 kDa heat shock protein, mitochondrial
alpha-1-antiproteinase precursor
alpha-1-antiproteinase precursor
alpha-1-antiproteinase precursor
elongation factor Tu, mitochondrial isoform 2

Gene
Name
Hsp90b1
Hspa8
Hspd1
SERPINA1
SERPINA1
SERPINA1
Tufm

transcriptional regulation & RNA processing
heterogeneous nuclear ribonucleoprotein A3
Hnrnpa3
heterogeneous nuclear ribonucleoprotein H
Hnrnph1
far upstream element-binding protein 2
Khsrp

81

Direction
of
Regulation
down
up
down
down
down
down
down
down
down
down

Fold
change
0.42
3.93
0.60
0.72
0.33
0.40
0.45
0.55
0.57
0.65

	
  
3.4 Discussion
In this study, the protein expression of primary isolated MECs from virgin mice was
compared with that of primary isolated MECs from pregnant and primiparous quiescent
mice of the same lineage. As previously mentioned, the methods of analysis used in
2DGE allow the discovery of protein changes occurring at a point for each stage of
development investigated, but only provide a fraction of all changes occurring. The
results for this set of experiments included an even smaller fraction that expected. The
small number of identifications could have been a result of low protein abundance in the
samples run, as original protein concentration was lower than desired and the procedures
had to be repeated several times due to technical difficulties. Another possibility, though
not as likely, is that the proteins have not yet been identified and did not match any NCBI
database information. This low number of protein identities must be kept in mind when
reading the following discussion, as it is more difficult to put together a possible scenario
occurring in the cell with such a small subset of information. This being said, the trend of
down regulation in both comparisons relative to the virgin MECs is likely a true
occurrence. In the virgin to pregnant comparison, only 10 of the 67 differentially
expressed spots were up regulated in the pregnant MEC. In the virgin to primiparous
quiescent comparison, only 19 of the 73 differentially expressed spots were up regulated
in the primiparous MEC. The spots that were successfully identified closely mirrored this
trend of down regulation from the virgin state with only 5 out of 36 and 3 out of 31 spots
being up regulated in the pregnant and primparous MEC, respectively.
In addition to the small data set, another variable to consider when reviewing the
following information is the possibility of contaminating cell types. Though the aim of
82

	
  
the isolation procedures was to end up with isolated luminal mammary epithelial cells,
there are many more cell types in the gland that could have remained in the final pellet.
The most probable contaminating cell type would be myoepithelial cells, followed by
endothelial cells and leukocytes. While the presence of adipocytes, fibroblasts, and
erythrocytes is also possible, specific and effective steps were employed for their
elimination and they possess phenotypes distinct from the MECs and were not seen when
the cells were isolated and examined microscopically.
One last consideration is the stage of the estrous cycle in which the virgin and
primiparous quiescent mice were harvested. This factor was not monitored or confirmed
on the date of harvest, resulting in no knowledge regarding in which stage samples were
taken or consistency in stage of cycle across these different samples. As mentioned in
chapter 1, the activity of the cells does change with stage in estrous cycle and this would
very likely have an effect on the protein expression profile of these cells.
Although there were disappointing limitations based on the data obtained, and the
variables mentioned above must be considered when analyzing the resulting data,
proposed scenarios based on the changes in the protein profiles in the different stages of
development were very interesting. The seemingly high abundance of many protein types
in the virgin MEC compared to both other stages of development were surprising and
further investigation into this phenomenon would be a fascinating comparator.

A

discussion of both comparisons performed and the possible events occurring in these cells
will follow.
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3.4.1 Virgin vs Pregnant Comparison
3.4.1.1 Cytoskeleton
All but one of the identified proteins related to cytoskeletal dynamics were down
regulated from the virgin to the pregnant state. This may first seem surprising as it may
seem that differentiating cells would require reorganization and increased cytoskeletal
function would be required, but when the individual proteins are investigated a possible
logical scenario is revealed. PDZ and LIM domain protein 1 (PDLIM1, also known as
CLIM1) and LIM and SH3 domain protein 1 (LASP1) were both down regulated from
the virgin to the pregnant state of the MEC. PDLIM1 has been found in close association
with hormone receptor, ERα and is a co-regulator of ERα’s transcriptional targets. Its
expression has been found very high in less-differentiated and aggressive breast tumors,
and has also been found to block differentiation in several cell types, including MEC in
vitro (Johnsen et al., 2009). LASP1 is an actin binding protein that is required for cell
migration and is also highly expressed in breast tumors (Lin et al., 2004). The down
regulation of these proteins in the primary pregnant MEC might indicate that the
proliferation and reorganization of early pregnancy has ended and the differentiation of
these cells into the lactating phenotype can be performed. Two lamin proteins were also
down regulated in the pregnant state: prelamin A/C (LMNA) and lamin B1 (LMNB1).
The lamin proteins have long been known as the major component of the nuclear lamina,
providing structure and stability to the nuclear envelope as well as serve as anchor points
for chromatin. Now they are thought to play other roles in processes such as DNA
synthesis, transcription, and apoptosis (Goldman et al., 2002). The down regulation of
these proteins is interesting, especially since the loss of LMNB1 has been associated with
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cell senescence in previous investigations (Sadaie et al., 2013; Freund et al., 2012). Three
keratins (KRT) were also identified. KRT1 and KRT16 were down regulated in the
pregnant state, while KRT19 was one of the few proteins that were up regulated. KRT16
has been reported as a normal resident of the mammary gland (Pellegrino et al., 1988),
while it was surprising to see differential expression of KRT1, as previous investigation
has reported it as being absent in all stages of mammary development (Mikaelian et al.,
2006). The up regulation of KRT19 was of interest due to the few proteins that showed
this direction of expression. The increase in KRT19 in the pregnant state is in agreement
with previous reports that its expression is highest during pregnancy and lactation. It is
indicative of low proliferation and increased ability for milk component secretion,
suggesting gland is in the differentiating stage following the spike in expansion
mentioned in chapter 1 (Bartek et al., 1990).
Overall, the differential expression of the cytoskeletal proteins from virgin to the
pregnant state imply that the cells isolated from the pregnant glands are in the
differentiating stage following the highly proliferative stage of early pregnancy with
decreased motility and increased indicators of differentiation.

3.4.1.2 Metabolism
All proteins involved in metabolic processes were down regulated in the pregnant state
compared with the virgin state with the exception of one. Long-chain specific acyl-CoA
dehydrogenase (ACADL) was increased in expression in the pregnant primary MEC,
while short chain acyl-CoA dehydrogenase was decreased. Though many proteins in
metabolic processes were not identified and their direction of regulation is unaccounted
85

	
  
for, the proteins that were identified suggested mass decrease in energy metabolism
compared to the virgin state. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
fructose-bisphosphate aldolase A (ALDOA) down regulation suggest decreased
glycolysis. Whether there is a lower influx, a build up and storage of glucose, or use for
other processes at this point in development cannot be determined by the data gathered,
but it does not appear that glucose is entering glycolysis at as high of a rate as in the
virgin MEC. The trend of lower energy generation continues with a decrease seen in
dihydrolipoamide

dehydrogenase,

aconitate

hydratase

(ACO2),

and

malate

dehydrogenase, which function in the conversion of pyruvate to acetyl CoA and the TCA
cycle. Malate dehydrogenase can also aid in the generation of NADPH, which also may
be decreased based on the down regulation of transketolase, a member of the pentose
phosphate shunt. The trend suggests that less energy generation is occurring in the
pregnant state than the virgin state, possibly suggesting that differentiated state of the cell
is more energy efficient. One last protein is a member of the heat shock proteins, but has
been shown to have regulatory effects on metabolism. Heat shock protein 75 kDa
(TRAP1) is down regulated in the pregnant state relative to the virgin state. This is
interesting because of a previous report that deficiency in TRAP1 leads to an increase in
mitochondrial respiration, fatty acid oxidation, and a buildup of TCA cycle intermediates,
ATP and reactive oxygen species (ROS), while also suppressing glucose metabolism. In
addition to metabolic effects, its decrease is also associated with increased cell
invasiveness (Yoshida et al., 2013). While there is no evidence of increased respiration
and fatty acid oxidation in our data, there is also no evidence of its suppression and there
is evidence of suppression of glycolysis. The decrease in TRAP1 may be partially
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responsible for depression of glucose metabolism in this investigation, though the
cytoskeletal evidence suggests increased stability and polarization rather than mobility
and invasiveness.
Overall the interesting trend of metabolic processes was a decrease in activity in the
pregnant state of the cell, which means it was high in the virgin state. This is an
interesting phenomenon that might be explained in several ways. Perhaps the virgin MEC
requires more energy use due to the fluctuations in proliferation and regression seen with
the estrous cycle, or maybe the difference in available nutrients in the blood stream due to
the hormones of pregnancy has an effect on metabolic regulation and the use of glucose
in the two states of the cell.

3.4.1.3 Protein synthesis and processing
In addition to the TRAP1, two other heat shock proteins were identified as differentially
expressed in this comparison. Heath shock protein 1A (HSPA1A) is down regulated in
the pregnant MEC. This is a stress-induced HSP and helps the cell manage aggregation of
denatured proteins in stress conditions. In contrast, heat shock protein 70 cognate
(HSPA8) was up regulated in the pregnant MEC. This protein is 86% identical to
HSPA1A, but is a constitutively expressed protein that acts as a housekeeper for the cell,
aiding in protein folding and transport as well as managing denatured protein aggregation
in times other than just high stress (Daugaard et al., 2007). Perhaps the up regulation of
HSPA8 balances the decreased need for HSPA1A and the state of the pregnant MEC is in
a less stressful state than the virgin MEC. Though not many proteins in this category
were identified, the ones that were indicate a lower amount of protein relative to the
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virgin state. Alpha-1-antiproteinase (SERPINA1) and elongation factor tu (TUFM) are
both expressed at a lower level in the pregnant state than the virgin state. These proteins
inhibit serine proteases and aid in the production of proteins by helping with the binding
of tRNA at the ribosome, respectively (Kalsheker, 1988; Stark et al., 1997). This would
allow increased protein degradation and decreased protein production, though these are
only two of a multitude of proteins involved in these processes for which we do not know
the direction of regulation.

3.4.1.4 Secreted proteins
Interestingly, there were several identified proteins that are secreted and typically found
circulating in the plasma that were identified in this comparison. Albumin (ALB), alphafetoprotein (AFP), and serotransferrin (TF) were all identified as down regulated in the
pregnant state. The function of AFP is not well understood, though it is thought to be
responsible for the transport of various ligands such as fatty acids and heavy metals.
Roles as a growth promoter and a growth suppressor have both been assigned to this
protein and it has been recognized as a protein present during pregnancy that has lasting
protective effects from breast cancer risks (Vakharia and Mizejewski, 2000; Parikh et al.,
2005). This is very interesting since this protein was decreased in the pregnant state
versus the virgin state of the MEC. The protein responsible for iron transport, TF, was
also decreased in the pregnant state. This protein is typically found in milk product
during lactation, but the decrease in pregnancy from the virgin state in this investigation
might be explained by the decreased need of iron at that moment of cell isolation. Iron is
required as a cofactor during DNA replication and growth, which, as previously
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mentioned, might not be occurring in the pregnant MEC at their stage of development
(Gomme and McCann, 2005). Albumin is also a component of the final milk product and
though its down regulation from the virgin state might be surprising, the lack of up
regulation is not as the inclusion of protein transport into the alveolar lumen may not yet
have began.

3.4.1.5 Other identified proteins
Voltage-dependent anion channel 2 (VDAC2) was found decreased in abundance in the
pregnant state relative to the virgin state of the MEC. This protein functions as an ion
channel in the mitochondrial outer membrane and is responsible for transport of
metabolites such as ATP and ADP across the membrane (Rostovtseva and Bezrukov,
2008). Perhaps since the metabolism appears suppressed in the pregnant cells, the
regulation and transport of metabolites is also reduced and VDAC2 is decreased due to
lack of necessity. Another interesting expression profile of the pregnant state relative to
the virgin state is the decrease in abundance of two proteins related to immune and stressfighting function. Catalase and immunoglobulin heavy chain, variable region (IGHVDJ)
were both found down regulated in the pregnant MEC. Catalase is responsible for
protection against reactive oxygen species and IGHVDJ is the heavy chain portion of
immunoglobulin. The decrease in catalase agrees with the story told by the heat shock
proteins, that possibly the pregnant MEC does not require as much of this protein due to a
less stressful state. It is interesting that IGHVDJ is not only present in the virgin and
pregnant cells, but that it varies in regulation as this protein is only produced by B cells of
the immune system. Immunoglobulins are transported from the blood into the final milk
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product, but this was thought to occur near parturition. The explanation of a
contaminating cell type during the virgin isolation should not be overlooked in this
situation.

3.4.2 Virgin vs Primiparous Quiescent Comparison
3.4.2.1 Cytoskeleton
The identified cytoskeletal protein expression profile for the primiparous quiescent MEC
varies only slightly from the pregnant MEC relative to the virgin state of the cells.
LASP1 and LMNB1 were the only two present in the virgin/pregnant comparison that
were not identified as differentially expressed between the primiparous quiescent and
virgin states. PDLIM1, LMNA, and the keratins (1, 16, 19) all show the same direction of
regulation as seen in the virgin/pregnant comparison above. This similar expression
pattern for the pregnant and quiescent states relative to the virgin state appear to represent
persisting differences in the MEC after one pregnancy and lactation event. Since
PDLIM1 has been implicated in aggressiveness of breast cancer (Johnsen et al., 2009),
this continued decrease in abundance could support the idea that it may play a role in
tumor metastases and decreased risk following a pregnancy. In the same way, the
increased expression of KRT19 indicates a continued state of a higher order of
differentiation, which has been seen histologically and is a well-documented
phenomenon (Bartek et al., 1990; Richert et al., 2000; Daniel and Silberstein, 1987). In
addition to the proteins that were identified in the previous comparison, actin,
cytoplasmic 1 (ββ-actin; ACTB) also appeared as up regulated in the quiescent state
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relative to the virgin state. Increased actin is surprising as it indicates cell movement or
cytoskeletal rearrangement. Perhaps as beta-actin was increased in the differentiated
HC11 cells, the quiescent cells have persisting cytoskeletal changes from the previously
lactating phenotype in which the cytoskeletal rearrangement was necessary for transport
of milk components to the alveolar lumen.

3.4.2.2 Metabolism
The metabolic state of the primiparous quiescent MEC appears to be suppressed relative
to the virgin state of the cells. The glycolytic enzymes identified in the last comparison
were not indicated as differentially expressed between the virgin and primiparous
quiescent states, so the regulation of this pathway in this investigation cannot be
speculated upon. Enzymes involved in the TCA cycle and respiratory chain, however,
were identified. Dihydrolipoamide dehydrogenase (DLD) is on of three enzymes that
makes up the pyruvate dehydrogenase complex which converts pyruvate to acetyl CoA
for entrance into the TCA cycle (Patel and Korotchkina, 2006). This means that there is
either a lower amount of acetyl CoA entering the TCA cycle or the substrate is coming
from another origin. DLD also plays a role in the conversion of 2-oxoglutarate to
succinyl-CoA in the TCA cycle. Aconitate hydratase (ACO2), succinate dehydrogenase
flavoprotein subunit (SDHA), and fumarate hydratase (FH) are also all down regulated
relative to the virgin state. These all catalyze reactions of the TCA cycle. SDHA links the
TCA cycle to the respiratory chain. In addition to the TCA cycle link being decreased,
ATP synthase subunit beta is down regulated in the primiparous state. This is a part of the
F1, catalytic portion of the ATP synthase enzyme and required for the production of ATP
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in the respiratory chain (Wang and Oster, 1998). Interestingly, the only identified protein
that was differentially expressed in both comparisons, but displayed opposite directions
of regulation was electron transfer flavoprotein subunit alpha (ETFA). Increased
abundance of ETFA in the primiparous state relative to the virgin state was detected in
this investigation, while it was down regulated in the pregnant state relative to the virgin
state. The role of ETFA is to transfer electrons from several dehydrogenases to the
respiratory chain (Toogood et al., 2007). The increase in this protein and decrease in
ATP5B suggests an interesting contrast in respiratory activity. Production of NADPH
might also be reduced in the primiparous state as one of the major PPS enzymes, TKT, is
down regulated. Perhaps the lipid metabolism pathways are suppressed altogether, as the
ACADS is also reduced in this state. Aldehyde dehydrogenase (ALDH2) is the last
identified metabolic protein that is down regulated in the primiparous state. Though
mostly known for alcohol metabolism, ALDH2 can also participate in other metabolic
processes such as the series of reactions resulting in the conversion of threonine to
pyruvate (Salway, 1994), which was a proposed reason for its up regulation in
differentiated HC11 cells in the previous chapter.
Overall metabolic activity in the primiparous quiescent MEC relative to the virgin MEC
reveals a suppression of activity, much like what was seen in the virgin/pregnant
comparison. This with the similarities in cytoskeletal proteins, which indicated a higher
order of differentiation may suggest the greater requirement for energy by the less
differentiated, virgin state of the cell.
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3.4.2.3 Protein synthesis and processing
Similar to the previous comparison, HSPA8 was up regulated from the virgin state to the
primiparous state. Heat shock protein 84 (HSP90AB1), endoplasmin (HSP90B1), and 60
kDa heat shock protein (HSPD1) were all down regulated in the primiparous state.
HSP90B1 and HSPD1 function in the endoplasmic reticulum and the mitochondria,
respectively, to participate in protein folding and transport (Chen et al. 2005; Koll et al.,
1992). The cytosolic HSP90AB1 is constitutively expressed and involved in folding of
cell regulatory proteins and refolding of stress-denatured proteins (Chen et al., 2005).
Perhaps the up regulation of HSPA8 was enough to regulate stress-denatured proteins and
the need for folding of cell regulatory proteins was decreased in the non-proliferative
state of the primiparous relative to the virgin MEC. Elongation factor 1-gamma (EEF1G)
and TUFM were also both down regulated in the primiparous MEC. This indicates
decreased translation as these elongation factors aid in the delivery of tRNAs to the
ribosome to allow production of proteins. Lastly, SERPINA1 was again found down
regulated relative to the virgin state of the MEC. Just as in the pregnant MEC, the
regulation of the identified proteins related to protein processing occurring in the
primiparous MEC suggested a less stressful environment with decreased protein
production and the potential for increased degradation.

3.4.2.4 Transcriptional regulation and RNA processing
In addition to the decrease in protein abundance, three proteins involved in transcriptional
regulatory processes were also down regulated. Two heterogeneous nuclear
ribonucleoprotein members, A3 and H, were decreased in abundance in the primiparous
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state relative to the virgin state. These proteins are involved in the cytoplasmic trafficking
of RNA, pre-RNA processing, and mRNA maturation (Ma et al., 2002; Papadopoulou et
al., 2012; Bent et al., 1995). Far upstream element-binding protein 2 (KHSRP) is also
decreased in primiparous cells. This protein participates in RNA splicing and plays a role
in the production of micro RNA that leads to gene regulation (Treiber et al., 2012).
Though only three proteins in this category were identified, the indication from their
regulation and the regulation of protein processing is a decrease in production of
transcripts and proteins in the primiparous MEC relative to the virgin state.

3.4.2.5 Secreted proteins
Just as in the pregnant/virgin comparison, several typically secreted proteins were
identified and decreased in abundance in the primiparous MEC relative to the virgin state
of the cell. Albumin, AFP and TF were once again all identified as higher in the virgin.
Since the same pattern is seen in the pregnant cells as the primiparous cells relative to
virgin MEC, the question then shifts focus to why the virgin state might be displaying
higher levels of these proteins, especially AFP which is supposed to be highest in
pregnancy and is reported to have lasting effects on decreased risk of breast cancer
(Vakharia and Mizejewski, 2000; Parikh et al., 2005). The decrease in TF might be
explained in the same manner as it was for the pregnant state - iron is required as a
cofactor during DNA replication and growth, which might not be occurring as often in
primiparous MEC as in virgin MEC (Gomme and McCann, 2005). The abundance of
albumin in the virgin state is still surprising and further investigations would help reveal
whether this pattern of expression is consistent and served a purpose.
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3.4.2.6 Other identified proteins
Voltage dependent anion channel 2 and IGHVDJ were both also down regulated in the
primiparous MEC relative to the virgin MEC. Without more information about other
related proteins, limited speculation can be made on their roles in the virgin cells, though
the previous proposed explanation for decreased VDAC2 goes along with the seeming
reduction in metabolism in the primiparous MEC relative to the virgin as well. A reduced
metabolic load of the mitochondria may lack the need of more VDAC2 in the
primiparous cells. One other protein of interest was not found as differing in abundance
between virgin and pregnant states. Cell division cycle 42 (CDC42) is a protein that plays
a role in cell cycle progression, cell polarity, migration and differentiation and has
recently reported as required for MEC morphogenesis in vitro (Bray et al., 2011). This
protein is also overexpressed in certain breast cancer types (Fritz et al., 2002). The down
regulation of this protein from the virgin to the primiparous state of the MEC might be an
interesting further investigation, as it has already been implicated in the possible role of
hyper-proliferation and migration of cancer cells (Bray et al., 2013).

3.4.3 Comparison to Previous Studies
As mentioned previously, an investigation much like the one reported in this chapter has
been performed in the same lab on isolated primary pregnant MEC compared with
lactating MEC (Strand, 2012). Many identified proteins in the two comparisons were
shared, though their regulation varied among them. The comparison between the
pregnant and lactating states of the primary MECs showed largely up regulated metabolic
processes. Many enzymes involved in fatty acid synthesis, the TCA cycle and the
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respiratory chain were increased from the pregnant to the lactating state. This would be
expected due to the high demand of the cell to produce and transport components into the
alveolar lumen. An interesting comparison would be that of the virgin MEC and lactating
MEC, as the pregnant MEC appeared to have decreased metabolic activity relative to the
virgin cells. The down regulation of the cytoskeletal proteins, LASP1 and PDLIM1, was
also seen in the previous pregnant/lactating comparison as it was in the virgin/pregnant
comparison. This indicates that they are highest in the virgin state of the MEC, which
may be an interesting topic of investigation due to the prior reports of high expression of
these proteins relating to breast cancer (Johnsen et al., 2009; Lin et al., 2004). Patterns of
protein synthesis and processing were similar to what was found in the HC11 in vitro
investigation discussed in Chapter 2. Protein processing was down in lactating MEC even
from pregnant MEC, which again indicates the high levels of protein synthesis and
processing in the virgin MEC. A study examining the comparisons between many states
of development in one data set would be very useful in finding changes and trends of
protein category expression profiles among these MEC.
As mentioned in Chapter 1, D’Cruz and colleagues performed a microarray on parous vs.
nulliparous rodent glands and found decreased expression of transcripts involved in
proliferation and increased expression of genes involved in growth inhibition. Similar
results were found by Ginger and colleagues when the expression profile of rats without
exposure to gestational hormones was compared to rats that had previously been
subjected to induced pregnancy through E and P levels (2001). In addition they found
differences in metabolic genes and genes involved in cell-cell contact and the ECM.
Balogh et al studied the breast tissue from nulliparous and parous women (2006). This
96

	
  
study also found evidence of increased immune surveillance and proliferation inhibition
through apoptotic factors in parous breast tissue as well as changes in genes involved in
cell trafficking, cell signaling, transcription and translation, and others.

These

investigations were performed on whole tissue from the breast, whereas the study
recorded here was performed on isolated mammary epithelial cells. Though the
possibility of contamination with other cell types of the mammary gland is not negligible,
the data is likely more indicative of the molecular occurrences in that particular cell type
than the others.
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CHAPTER 4 – Development of a database for organization and analysis of mammary
epithelial cell data: BROVINE
4.1 Introduction
In today’s world of seemingly limitless ability for data generation from the scientific
community, making sense of the vast sea of information is the largest obstacle. The
ability of experts from different fields to communicate effectively and work together has
become more important with this surge of data generation and the need for
interdisciplinary communication is recognized and well documented (Wolkenhauer and
Hofmeyr, 2013; NRC, 2010; Howe et al., 2008). Computer programs are needed for
storing, organizing, and analyzing these large data sets and the scientists that produce this
data are not likely capable of creating the advanced programs needed. The Peterson lab’s
investigation into the changing MEC through different stages of development has
generated relatively small data sets that include lists of protein names that have changed
in expression levels from one state to the next. The lists are growing and the desire to find
relationships among the proteins on these different lists is a difficult achievement due the
number of them present. A computer could accomplish this process much more quickly
and easily than a human – if the right program existed.
The Peterson lab collaborated with Dr. Alex Dekhtyar from the computer science
department in order to create a program that could help organize and analyze the data sets
being produced. The aim of the database is to help unveil potential transcriptional
regulators of mammary development by using lists of proteins, or their associated genes,
that are differentially expressed between different stages of development in the MEC.
Lists of potential transcription factors (TFs) for each differentially expressed gene are
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generated with an online tool and this information needs to be managed as well. Ideally,
the database would aid in upload and organization of data from many experiments
performed in any species looking at any stage of mammary development. The database
would then be responsible for organizing and analyzing these lists of genes and
corresponding TFs to uncover relationships among species, genes, and the regulation
patterns of these genes.
The following chapter may not be typical of a scientific paper as it is not filled with data
sets and facts, rather a discussion regarding the personal experience of interdisciplinary
learning and a tour of the end product. It discusses different steps taken and progress that
has been made to begin development of software that can aid in the analysis of the MEC
data sets being generated more quickly and in more depth than would otherwise be
possible.
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4.2 Methods
4.2.1 BIO 441
My participation in this class occurred after my participation in CSC 366 (described
below), however, the information learned in this class would have been very useful prior
to my involvement in CSC 366 so it will be explained first. The class was taught by Dr.
Anya Goodman and included lecture and lab. It was split into two major learning
objectives; students learned to annotate genes and participated in the Genomics
Education Partnership by annotating a portion of the Drosphilia melanogaster genome,
and they worked with computer science students to create computer programs that
performed tasks related to genome assembly and analysis. The lab was typically held
with computer science students from CS 448 taught by Dr. Alex Dekhtyar. The two
classes were first taught basics of the others’ discipline to provide background knowledge
that would help with the collaboration that took place during lab sessions. Teams of BIO
441 students wrote program requirements outlining desired functionality for computer
programs and CS 448 students wrote code to create said programs. As each portion was
completed, the BIO 441 students would run tests and report back to the CS students in
order to fix bugs found in the programs until their performance was satisfactory. The
process of software development was introduced to BIO students in this way while CS
students gained experience with a real client outside of the discipline.
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4.2.2 CSC 366
To begin development of the database desired for the Peterson lab’s growing data set, we
became the clients for Dr. Alex Dekhtyar’s class of computer science students (CSC 366)
whose job was to produce our desired product. The class began with a brief lesson on
genetics and transcriptional regulation to give the CS students a background for the
database needed for our project. In order for our desired program plan to be conveyed
properly to the CS students, terms needed to be defined and exact functions needed to be
specified so the developers knew what code they needed to write; we constructed a
document containing use cases, which outlined the steps describing our desired
interactions with the program. The document outlined specifics regarding data insertion
and manipulation functionality, browsing and filtering functionality, and analytical
functionality (see Appendix A). From that point the class broke into teams and each team
was in charge of developing prototypes of the product we requested. The developers used
our document to formulate requirements and begin to design the software. As portions of
the database were implemented they were tested with initial data we provided.
Adjustments were made based off of bugs found during testing and clarifications of
desired functionalities. At the end of the class, the complete database products were
presented to us and one was chosen for further development. The database chosen was
web-based and was named “Brovine” by the developing team. It was developed by a
team of men and it was developed using data from a bovine cell line, which led to the
developers naming the program “Brovine.”
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4.2.3 Individual database development
The desired functionality of the database went beyond the scope of the CSC 366 class.
One team member, Therin Irwin, that helped create Brovine continued development of
the database through individual consultation with the Peterson Lab as his senior project.
Further improvements were implemented in a similar manner. Documents similar in form
to the use case document presented in Appendix A were written containing desired
functionalities. Requirements were then formulated and the new code was written. The
new portions of the program were then tested by the Peterson lab and a report was sent
back with any bugs detected or changes desired.
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4.2.4 Data Preparation
The data used to develop the database was generated by a 2DGE experiment performed
by former lab mate, Laura Strand. A bovine cell line, MAC-T was cultured and protein
was extracted and analyzed in the undifferentiated and differentiated states. Differentially
expressed proteins between the two states were identified and a list was generated.
Promoter regions for the genes of this list of differentially expressed proteins were
obtained from their associated gene sequence found on the NCBI genome database,
starting 1950 nucleotides before the transcription start site and ending 50 nucleotides
after the transcription start site. Lists of transcription factors associated with each of these
genes were generated using Transcription Element Search System (TESS). TESS was an
available online tool that identified potential transcription factors for a gene based on
presence of the TF’s regulatory elements in a provided sequence. The resulting product
was an excel file containing worksheets listing the search parameters used and the
potential TFs associated with the provided promoter sequence. These excel files were
then converted to .csv files to allow loading into the developing databases in CSC 366.
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4.3 Results
At the end of the CSC 366 class, all use case specifications (Appendix A) excluding the
extra credit items were completed by many of the developed databases including the
chosen database, Brovine. These included pages labeled Upload, Experiment Hierarchy,
Gene Summary, TF Summary, Gene Search, and TF Popularity.
After continued development with Therin Irwin, existing pages were updated further and
a page labeled TF Subtract was added. The following were the final pages containing the
most important functionalities and their descriptions:
1. Upload – The upload page of the Brovine database allows individual gene or bulk
file upload into the web-based database. The user is able to browse the files on their
computer to upload into the database. Files are uploaded in .csv format, which are
converted from excel files. A snapshot of this page is shown in Figure 7.

Figure 7. Upload page of the Brovine database.
	
  

104

	
  
2. Experimental Hierarchy – The experimental hierarchy page allows the used to filter
down through the uploaded data to find information on specific known entities. The
flow of the information begins with a choice of species, followed by comparison,
followed by experiment, followed by gene, followed by transcription factor,
followed by regulatory sequence. When a regulatory sequence is selected, more
information about it is displayed including the start position, its length, the sense,
and the exact nucleotide sequence. This page also allows editing of the information
that was uploaded as well as the ability to hide information. A snapshot of this page
is shown in Figure 8.

Figure 8. Experiment Hierarchy page of the Brovine database.
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3. Gene Summary – This page provides a list of all genes populating the database in a
table form. Information provided in the table includes the gene name and
abbreviation, the number of comparisons in which the gene is found, and the number
of experiments in which the gene is found. The table is sortable by any column.
When a gene is selected, another table appears listing the experiments in which the
gene is found and the following information found in that experiment: the
corresponding comparison and species, the gene’s regulation in that experiment, and
the position of the gene in that species’ genome. The second table listing the
experiments can be filtered by regulation. A snapshot of this page is shown in Figure
9.

Figure 9. Gene Summary page of the Brovine database.
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4. TF Summary – This page provides a list of all transcription factors populating the
database in a table form. Information provided in the table includes the TF name, the
number of genes in which the TF is found, and the total number of occurrences of
the TF in the database. The table is sortable by any column. When a TF is selected,
another table appears listing the occurrences and including the following information
about each one: the length and sense and beginning position of the sequence, the
species, comparison and experiment the occurrence exists, the gene in which it was
found and that gene’s regulation in the corresponding experiment. The second table
listing the occurrences can be filtered by regulation. A snapshot of this page is
shown in Figure 10.

Figure 10. TF Summary page of the Brovine database.
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5. Gene Search – This page allows the user to select any number species, comparisons
and experiments to provide a list of TF present in the selected categories. The user
can then select any number of specific TFs from this list and specify filtering
options. The database will then use these selections to provide a list of genes
containing all of the selected TFs that meet the filtering requirements. A snapshot of
this page is shown in Figure 11.

Figure 11. Gene Search page of the Brovine database.
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6. TF Subtract – This page allows the user to select two separate groups of genes and
subtract the TFs present in one group of genes from the list of TFs present in the
other group of genes. This allows the user to find TFs that might have potential
significance in an experimental group of differentially expressed genes by showing
only the TFs that are present in the experimental comparison, but not in a control
group of genes. The final list provided includes the TF names, the number of genes
in which they appear, and their number of occurrences. A snapshot of this page is
shown in Figure 12.

Figure 12. TF Subtract page of the Brovine database.
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4.4 Discussion
Development of the database is not complete, but much has been accomplished. No
publishable experimental results have been obtained from the database to this point.
Further functionality is desired from this web-based program related to time course
studies and regulation of genes sets throughout the duration of them. The TF Subtract
page was a large advancement in this direction, but eventual development will aim at
creating regulation profiles for different gene transcripts found at different time points of
mammary development, grouping these genes based on their profiles, then using the
functionality of the TF subtract page in order to find TFs that could potentially be driving
the regulatory profiles of these groups of genes. When a few key TFs are found by the
database that have potential of driving regulatory mechanisms of mammary development,
experiments can be performed to confirm or refute these factors’ role in development.
Other groups have designed software tools similar to the one we are attempting to
generate. A description of other, similar tools follows. TFM-Explorer has the goal of
identifying over-representation of transcription factor binding sites within a set of userdefined genes (Tonon et al., 2010). This seems to be a useful tool for finding overrepresented transcription factors that works on the basis of probabilities of sequence
presence, but does not appear to have a subtraction of a control set. Without the
subtraction it would be hard to determine which transcription factors are important in
solely the cell model in which the investigator is interested or in many models.
CORE_TF performs a search for over-represented transcription factor binding sites based
on user-provided ENSEMBL gene IDs and user-defined promoter regions (Hestand et al.,
2008). It presents a rather overwhelming table listing all identified binding sites in both
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the control set of genes and the users’ genes of interest. This tool has a similar first goal
of our database by finding binding sites taking into account a control set and has the
ability of finding homologous genes. CARRIE is a tool that accomplishes goals very
similar to ours, allowing the user to input microarray data and then proceeding to
determine gene expression changes and identify likely transcription factor binding sites
regulating the co-regulation of these genes. It also goes to the next step to construct
regulatory networks, as is one of our final goals (Haverty et al., 2004). This database
seems to be a great model for what we would like to accomplish, but with updated data
input capabilities, as RNAseq is the new way to analyze gene expression, and additional
ability to identify promoter patterns as mentioned above. We can use the lessons provided
by these other tools to improve on their functionality in ours.
The interdisciplinary collaboration experienced throughout the development of this
database was extremely productive for all parties involved. The computer scientists and
animal scientists were able to teach one another about their respective fields and the
difficulties that can arise in the communication between the two disciplines was realized
and eventually overcome. The Peterson lab was exposed to the process of software
development and learned how to effectively communicate software requirements to the
developers, including the level of specificity required. The computer scientists learned
the importance of understanding the information they are working with and the basics of
the field for which they are developing software. This real world experience should
benefit all parties by giving them insight into the growing reality of interdisciplinary
studies and the necessary collaboration between the technical and science fields.
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